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Abstract
There were 102 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR) in 2014, which is a
6 % decrease on the 109 articles published in 2013. The quality of the submissions continues to increase. The 2013
JCMR Impact Factor (which is published in June 2014) fell to 4.72 from 5.11 for 2012 (as published in June 2013).
The 2013 impact factor means that the JCMR papers that were published in 2011 and 2012 were cited on average
4.72 times in 2013. The impact factor undergoes natural variation according to citation rates of papers in the 2 years
following publication, and is significantly influenced by highly cited papers such as official reports. However,
the progress of the journal’s impact over the last 5 years has been impressive. Our acceptance rate is <25 %
and has been falling because the number of articles being submitted has been increasing. In accordance with
Open-Access publishing, the JCMR articles go on-line as they are accepted with no collating of the articles
into sections or special thematic issues. For this reason, the Editors have felt that it is useful once per calendar year to
summarize the papers for the readership into broad areas of interest or theme, so that areas of interest can
be reviewed in a single article in relation to each other and other recent JCMR articles. The papers are presented in
broad themes and set in context with related literature and previously published JCMR papers to guide continuity of
thought in the journal. We hope that you find the open-access system increases wider reading and citation of your
papers, and that you will continue to send your quality papers to JCMR for publication.
Congenital heart disease, pulmonary arterial
hypertension, pregnancy, and cardiovascular
disease of the young
CMR of congenital heart disease is well established,
although high quality acquisition and interpretation
require training [1]. CMR is used in fetuses, [2, 3]
children, [4] and adults, [5, 6] often as a complement
to echocardiography, to avoid imaging with ionising
radiation, and reduce the need for invasive diagnostic
cardiac catheterisation [7]. CMR has a proven role in
idiopathic pulmonary arterial hypertension and its po-
tential utility in other forms of pulmonary arterial
hypertension is under study. Three dimensional data
acquisition is usual. 3D and 4D flow imaging, which
allows the visualisation of large scale vorticity and the
retrospective measurement of flow in vessels within
the volume covered, continue to be of interest.
Evaluation of a comprehensive cardiovascular magnetic
resonance protocol in young adults late after the arterial
switch operation for d-transposition of the great arteries
In this observational study, 27 adults with prior arterial
switch operation (ASO) for transposition of the great
arteries (D-TGA) underwent CMR for biventricular sys-
tolic function, myocardial scar burden, coronary ostial
assessment and myocardial perfusion during vasodilator
stress [8]. CMR provided conclusive diagnostic imaging
for coronary ostia in most patients (24/27). CMR stress
perfusion was normal in all. By contrast same day
single photon emission computed tomography (institu-
tional practice) imaging showed abnormalities in 54 %
of cases; abnormalities were incongruent with anatomic
coronary imaging and therefore considered false posi-
tives. Asymptomatic, clinically stable adult ASO patients
have low pre-test probability for inducible ischemia sug-
gesting routine surveillance with CMR stress perfusion is
unnecessary.
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Cardiovascular magnetic resonance parameters associated
with early transplant-free survival in children with small left
hearts following conversion from a univentricular to
biventricular circulation
This retrospective analysis reported CMR parameters
associated with transplant free survival with a biventri-
cular circulation after conversion of a univentricular
circulation to a biventricular circulation in two patient
groups [9]. In borderline hypoplastic left heart (n = 22),
higher LV end diastolic volume (minimum 22 mL/m2),
higher LV to RV stroke volume ratio (minimum 0.19)
and higher mitral to tricuspid inflow ratio were associ-
ated with successful biventricular conversions. In unbal-
anced atrioventricular septal defect with right ventricular
dominance (n = 10), which was a smaller subgroup with
only one death, no association of CMR parameters with
transplant-free survival with a biventricular circulation
were found. Despite that this is a difficult topic to study
with heterogeneous patients, and small sample size these
data suggest that CMR parameters can be used to predict
likelihood of successful biventricular repair in children
with hypoplastic left heart. CMR predictors were superior
to conventional echocardiographic measures.
Cardiovascular magnetic resonance of cardiac function
and myocardial mass in preterm infants: a preliminary
study of the impact of patent ductus arteriosus
The authors studied 45 preterm infants of which 16
had a patent ductus arteriosus (PDA) [10]. EDV, SV, LV
output, LV mass (corrected by weight) and EF decreased
with increasing corrected gestational age in 29“healthy”
neonates without a PDA. In the PDA group, shunt volume
by phase contrast CMR correlated with increased LV mass
corrected for postnatal age and gestational age and there
was increased LV size and output compared with the non
PDA group. However, ejection fraction and wall thickness
were not different between preterm infants with a PDA
and infants without a PDA suggesting that LV function is
relatively maintained.
Comparison of conventional autopsy and magnetic
resonance imaging in determining the cause of sudden
death in the young
Seventeen young patients with sudden death (mean
age 23 ± 11 years, 71 % male) who died between 2010
and 2012 were studied with 1.5 T MR and CT prior
to autopsy [11]. The most common cause of death
was cardiac (47 %) including ARVC (24 %) and ische-
mic heart disease (12 %). MR diagnosis was concord-
ant with autopsy in 12 patients, while in five cases,
cause of death remained unknown despite autopsy.
Dedicated post mortem MR imaging of the heart and
brain may allow identification of cause of sudden
death where conventional autopsy cannot be performed
for logistical, cultural or personal reasons.
Myocardial fibrosis in Eisenmenger syndrome: a descriptive
cohort study exploring associations of late gadolinium
enhancement with clinical status and survival
This group performed CMR with LGE in a cohort of 30
patients with Eisenmenger syndrome, mean age 43 ±
13 years, 20 female followed up for a median 7 years
[12]. LGE was present in 73 % of patients, specifically
in RV myocardium (70 %), RV trabeculae (60 %), LV
myocardium (33 %) or LV papillary muscles (30 %).
Myocardial fibrosis by LGE is common in Eisenmenger
syndrome, though not extensive and in this pilot study
its presence and quantity did not correlate with ven-
tricular size, function, degree of cyanosis, exercise cap-
acity, or survival in this pilot study suggesting that
routine clinical use of LGE in these patients is not to
date justified.
Cardiovascular magnetic resonance in pregnancy: Insights
from the cardiac hemodynamic imaging and remodeling
in pregnancy (CHIRP) study
There is relative paucity of data related to expected
haemodynamic changes in pregnancy assessed by CMR.
The objective of the Cardiac Hemodynamic Imaging
and Remodeling in Pregnancy (CHIRP) study was to
compare transthoracic echocardiogram and CMR in the
non-invasive assessment of maternal cardiac remodel-
ing during the peripartum period [13]. Thirty four
healthy pregnant women were recruited and studied
during the 3rd trimester and at least 3 months post-
partum (control values for the non-pregnant state).
CMR reference values for the increase in LVEDV and
LV mass associated with normal pregnancy are reported.
Transthoracic echocardiography consistently underesti-
mated LV volumes and mass compared to CMR. A limita-
tion in this study is that postpartum 3 month findings are
assumed equivalent to findings prior to pregnancy.
The distribution and prognosis of anomalous coronary
arteries identified by cardiovascular magnetic resonance:
15 year experience from two tertiary centres
This dual tertiary centre study retrospectively identi-
fied consecutive patients with an anomalous coronary
artery originating from the opposite sinus of Valsalva
(ACAOS, n = 116), of which 64 (55 %) had an inter-
arterial course, passing between the aorta and pulmonary
artery [14]. ACAOS patients had 58 MACE events at me-
dian 4.3 years follow up (five cardiovascular deaths, 5 PCI,
24 CABG and 24 myocardial infarctions). Events were sig-
nificantly more common in patients with ACAOS and an
inter-arterial course compared to those without an inter-
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arterial course, driven by surgical revascularization and
myocardial infarction.
Cardiovascular magnetic resonance assessment of
ventricular function and myocardial scarring before
and early after repair of anomalous left coronary
artery from the pulmonary artery
This case series reports three Tesla CMR findings in
eight patients with anomalous left coronary artery from
the pulmonary artery (ALCAPA) before and early after
(mean 4.9 ± 2.5 months) coronary reimplantation sur-
gery [15]. The group studied eight ALCAPA patients
prior to and early after coronary reimplantation. LV dila-
tation and dysfunction was present in all patients and
improved significantly after surgery. Despite impaired
myocardial perfusion and severely compromised LV
function, only 2/8 patients had LGE enhancement pre-
procedure which was associated with delayed recovery
of LV function in one and was still present postopera-
tively in both. New onset transmural scarring occurred
in two patients and in one left coronary artery stenosis
was detected and required reoperation.
High-resolution 3-dimensional late gadolinium enhancement
scar imaging in surgically corrected Tetralogy of Fallot:
clinical feasibility of volumetric quantification and
visualization
LGE enhancement is associated with adverse clinical
features in repaired tetralogy of Fallot (ToF) and RV
scar is the substrate for ventricular arrhythmia. This
study demonstrated high resolution 3D LGE at three
Tesla findings in 15 patients using a whole heart, respira-
tory navigated technique and evaluated a semi-automated
segmentation analysis [16]. Total right ventricular outflow
tract scar volume using the semi-automated method was
compared to manual segmentation as the gold standard in
15 patients with ToF. 14/15 patients had 3D imaging of
sufficient quality for LGE quantification and this showed
excellent agreement with manual segmentation with a sig-
nificantly faster analysis time.
Right ventricular adaptation to pulmonary pressure load
in patients with chronic thromboembolic pulmonary
hypertension before and after successful pulmonary
endarterectomy - a cardiovascular magnetic resonance
study
This is an insightful study of right ventricular adapta-
tion to pressure loading conditions in 65 patients with
chronic thromboembolic hypertension before and after
pulmonary endarterectomy using CMR combined with
haemodynamic measurements available from routine
right heart catheterization [17]. The authors demon-
strated that RV function is largely determined by after-
load and returns to normal once ventriculo-arterial
coupling and effective pulmonary arterial elastance are
restored by pulmonary endarterectomy.
Technical advances
The march of technological improvement never stops
and the cardiovascular system inspires considerable ac-
tivity, probably because it is challenging and ripe for
continued development. Advances reported in the jour-
nal have included real-time imaging, [18] dual transmit
RF, [19] and rapid functional assessment [20]. The full
breadth of new developments is described in the papers
in the section.
Analysis of temperature dependence of background
phase errors in phase-contrast cardiovascular magnetic
resonance
This paper looks more deeply into the underlying issues
behind the background phase errors that still represent a
major problem with regard to the accuracy of clinical
blood flow measurement [21]. The results showed the
close relationship between gradient mount temperature
changes during scanning and first order background
phase shifts. The conclusion of this study is that ad-
vanced correction methods may well be required that
take into account the gradient temperature and/or using
of concurrent field-monitoring to map gradient-induced
fields throughout the scan.
Method for calculating confidence intervals for phase
contrast flow measurements
This work was also focused on the subject area of the
accuracy of phase contrast flow measurement but in
this case on confidence intervals and how these were
affected by noise associated with accelerated imaging
[22]. The authors presented and validated a novel
method for determining the standard deviation of
flow or flow ratio measurements based on thermal
noise in Cartesian retro-gated phase contrast CMR.
Validation was achieved by comparison with repeated
measurements in a phantom and pseudo replica re-
constructions of in vivo data. The method could pro-
vide a useful tool directly integrated into flow analysis
software packages where confidence intervals could be
evaluated on the fly.
Towards highly accelerated Cartesian time-resolved 3D
flow cardiovascular magnetic resonance in the clinical
setting
3D phase contrast CMR has traditionally been limited
by long acquisition times. This study tested an 8-fold
acceleration of Cartesian time-resolved 3D flow [23].
Data acquisition was feasible in both healthy controls
and patients with complex congenital heart disease
with a nominal scan time of 6–7 min. The 3D dataset
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allowed demonstration of circular and helical flow pat-
terns within the Fontan circulation and showed good
agreement with quantification performed using 2D flow
velocity mapping.
Dual echo positive contrast bSSFP for real-time
visualization of passive devices during magnetic
resonance guided cardiovascular catheterization
This innovative sequence development for real-time
interventional CMR uses the concept of positive con-
trast of paramagnetic materials obtained with dephas-
ing gradients in a dual echo sequence that allows
both the dephasing gradient image and a more stand-
ard bSSFP image to be acquired simultaneously at
frame rates of 5–6 frames/s [24]. The approach was
demonstrated both in a phantom and a swine model
of left heart cardiac catheterisation to visualise a nitinol
guide wire. A near real-time image processing pipeline
was used to display the guide-wire as an overlay on the
bSSFP image during the procedure. A variable flip angle
scheme was also used to reduce the specific absorption
rate and hence device heating.
T1-mapping in the heart: accuracy and precision
This state of the art review of T1 mapping discusses
current methods for T1 quantification and provides
comparison of the differing techniques for native and
post-gadolinium measurement [25]. Both T1 values and
extracellular volume (ECV) fraction have been shown to
have prognostic value in a number of myocardial patholo-
gies. Inversion recovery techniques such as MOLLI have
excellent reproducibility when tightly controlled protocols
are employed, although are susceptible to magnetization
transfer. While saturation recovery methods may allow
greater accuracy, they are more prone to artefact and cur-
rently less reproducible.
Optimized saturation recovery protocols for T1-mapping
in the heart: influence of sampling strategies on precision
In recent years there has been considerable interest
in T1 mapping which has led to the development of
a wide variety of methodology for measurement [26].
This paper represents a much needed comparison and
parameter optimization of the saturation-recovery car-
diac T1 mapping sequence. This includes a very de-
tailed and rigorous evaluation of the 2 parameter
SASHA sequence with variable flip angle for T1 map-
ping, pre and post Gd using theoretical computations,
Monte Carlo simulations, and measurements from phan-
toms, and in vivo measurements in humans. The authors
conclude that “the ability to quantify the measurement
error has potential to determine the statistical significance
of subtle abnormalities that arise due to diffuse disease
processes involving fibrosis and/or edema and is useful
both as a confidence metric for overall quality, and in
optimization and comparison of imaging protocols”.
Simultaneous three-dimensional myocardial T1 and T2
mapping in one breath hold with 3D-QALAS
The group presented a novel method of 3D interleaved
T1 and T2 mapping which allowed acquisition of the
entire left ventricular myocardium in a single breath
hold [27]. When validated against MOLLI and Dual
Echo measurements in-vivo, there was reasonable agree-
ment for quantification of both T1 and T2 and excel-
lent agreement for in-vitro images. This method allows
rapid quantification of T1 and T2 in different tissues
using CMR.
MRXCAT: realistic numerical phantoms for cardiovascular
magnetic resonance
With the massive potential in CMR, to implement dif-
fering sampling and reconstruction approaches there
has been recent increased interest in simulators that
can be used to help optimize sequence parameters and
reduce artifacts for example [28]. This paper presents a
novel framework for CMR simulation made available to
the public via the internet. The focus is on sample
characteristics (incl. motion), sampling and reconstruc-
tion issues rather than simulated acquisition accuracy.
The so called MRXCAT is an extension for CMR of a
previously developed simulation framework. In this
study applications to cine and perfusion CMR are pre-
sented although extensions to other CMR modalities,
such as diffusion or flow encoded MRI, are potentially
possible.
High performance MRI simulations of motion on multi-GPU
systems
Another example of a CMR simulator again made avail-
able online is this simulator using a high performance
multi-GPU environment [29]. The authors describe ap-
plication of three different motion models that can be
applied with this simulator, allowing simulation of large
3D models. As the authors explain, the incorporation of
realistic motion models, such as heart motion and flow
models may benefit the design and optimization of exist-
ing or new MR pulse sequences, protocols and algo-
rithms that examine motion related MR applications.
The computational speed enabled by the GPU for this is
impressive.
Quantitative three-dimensional cardiovascular magnetic
resonance myocardial perfusion imaging in systole and
diastole
In this paper the authors have performed a prospective
study on 40 consecutive CAD patients to investigate the
feasibility of a 3D perfusion CMR technique for detection
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of significant coronary disease [30]. The novel CMR se-
quence used k-t principal component analysis (PCA)
reconstruction to enable a ten fold acceleration of the
acquisition which in turn enabled two complete 3D im-
ages to be acquired per cardiac cycle. Using this the au-
thors have also looked at the effect of acquisition time
point within the cardiac cycle to ascertain whether
there is any significant difference in myocardial perfu-
sion reserve as well as quantitative myocardial blood
flow between systolic and diastolic acquisitions. The
study demonstrated the feasibility of quantitative 3D-
perfusion CMR. Additionally, the results showed that
there are significant differences in systolic and diastolic
MBF estimates with both cardiac phases providing
comparable diagnostic yield but at different thresholds.
The systolic images had fewer artifacts and higher
image quality, suggesting that this phase may be pre-
ferred for future acquisition of 3D perfusion data.
Three-dimensional balanced steady state free precession
myocardial perfusion cardiovascular magnetic resonance
at 3 T using dual-source parallel RF transmission: initial
experience
During the last year there has been continued interest
in the use of dual-source parallel RF transmission to
improve CMR; in this case it has been applied to bSSFP
myocardial perfusion scanning at 3 T [31]. The parallel
transmission was used with B1 shimming to improve
the B1 homogeneity and provide a reduction in “SAR
hot spots” allowing reduced TR for the bSSFP acquisi-
tion. Multiple aspects are covered in the study includ-
ing B1 inhomogeneity, SNR and CNR, comparison of
k-t BLAST and k-t PCA in undersampled reconstruc-
tion, image quality and artifacts. The sequence compar-
isons are made on 25 volunteers and five patients. The
authors conclude that “three-dimensional bSSFP myo-
cardial perfusion CMR using local RF shimming with
dual source parallel RF transmission at 3 T is feasible
and improves signal characteristics compared with
TGRE but that image artefact remains an important
limitation of bSSFP perfusion imaging at 3 T”. It re-
mains unclear whether the improvements presented
are specific to particular scanner platforms or gener-
ally available as an overall improvement to the CMR
community as a whole.
Myocardial arterial spin labeling perfusion imaging with
improved sensitivity
Arterial spin labelling represents an alternative non con-
trast approach to perfusion measurement that has been
more widely applied outside the heart [32]. As with most
sequences the application in the heart is complicated by
motion. This paper describes the application of parallel
imaging to speed up the acquisition window to reduce
the apparent physiological noise in myocardial blood
flow (MBF) quantification. By reducing this noise more
temporally consistent measurements of MBF are provided
and this improves the sensitivity of the measurement.
Cardiac gating calibration by the septal scout for
magnetic resonance coronary angiography
In order to acquire sharp motion free images of details
in the heart such as coronary arteries or small late
gadolinium enhanced regions, it is necessary to accur-
ately define the patient specific diastasis period of the
heart cycle [33]. This paper describes a method for the
detection of the diastasis period by one-dimensional
projection ‘septal scout’ imaging along the ventricular
septum acquired at high temporal resolution (10 ms).
The application in this work is to improve the selection
of gating window for 3D coronary artery angiography.
The authors compare this method with the method
currently widely used for this, cine imaging. Qualitative
and quantitative analysis of vessel sharpness using the
septal scout demonstrated significant improvement over
the cine method. Furthermore, the Septal Scout was
shown to provide diastasis windows that are in close
agreement with those provided by TDE measurements of
septal motion.
Semi-automated left ventricular segmentation based
on a guide point model approach for 3D cine DENSE
cardiovascular magnetic resonance
The DENSE method of measuring myocardial strain is
becoming more established at least with the CMR clin-
ical research community and the following two papers
describe and test methods of simplifying ventricular
segmentation for the strain analysis [34]. In this paper a
semi-automated segmentation algorithm is presented
for 3D cine DENSE. The method uses a finite element
model to capture the volumetric epicardial and endo-
cardial surfaces and propagate each surface through the
cardiac cycle using the inherent displacement proper-
ties found in DENSE MR data. In this preliminary re-
port of the method the time for the segmentation
process is shown to be significantly reduced. The authors
claim this work to be a significant step towards the auto-
mation of 3D cine DENSE data analysis.
Simplified post processing of cine DENSE cardiovascular
magnetic resonance for quantification of cardiac mechanics
Another approach to simplifying the analysis is de-
scribed and evaluated in this paper [35]. Using their
technique, contour tracing can be reduced to three
contours per slice, instead of two contours per time
frame and this reduces interaction time significantly.
The authors evaluated the method on a large institu-
tional dataset (197 cases) of human and mouse data
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and found that the difference between the proposed
method and tracing every time frame to be smaller than
the inter-observer difference. They concluded that the
proposed method can therefore be used to reduce pro-
cessing time without affecting results.
Diffusion tensor imaging of the heart
Diffusion tensor imaging (DTI) gives information on
the mean intravoxel alignments of tissue microstruc-
tures using diffusion weighted imaging. It is used in
particular in the brain, where larger diffusion values
occur along nerve fibres in comparison to across fibres.
The technique can also be used with considerably in-
creased difficulty (due to motion) for the heart, how-
ever most work has been done in animals, or in ex-vivo
human hearts, because of the high difficulty of deriving
DTI data from the moving heart. Recently a more ro-
bust imaging sequence for in-vivo human cardiac DTI
has been described which makes human studies more
approachable. Recent work has shown in-vivo reproduci-
bility in humans in hypertrophic cardiomyopathy, [36, 37]
and histological validation in animals.
In vivo cardiovascular magnetic resonance diffusion tensor
imaging shows evidence of abnormal myocardial laminar
orientations and mobility in hypertrophic cardiomyopathy
Cardiac DTI was performed at 3 T in HCM and control
subjects and studied at end-systole and late diastole
[38]. In controls, the angle of the second eigenvector of
diffusion (E2A) relative to the local wall tangent plane
was larger in systole than diastole, consistent with the
expected changes of laminar orientation in the healthy
heart. HCM hearts appeared hypercontracted in systole,
with raised E2A, and retained high systolic-like angula-
tion in diastole, consistent with failure of ventricular
relaxation.
Probing dynamic myocardial microstructure with cardiac
magnetic resonance diffusion tensor imaging
This editorial, [39] reviews diffusion tensor imaging
(DTI) in hypertrophic cardiomyopathy from Ferreira et
al. [38]. It describes the microstructure of the heart in-
cluding the change in fibre orientation seen from the
epicardial to the endocardial surface, with large scale
orientation of myocytes seen ex-vivo by DTI. They de-
scribe the technical challenges of in-vivo cardiac DTI,
including long acquisition times and the challenge of
differentiation of diffusional and bulk motion in the
beating heart compared to ex-vivo.
Intercentre reproducibility of cardiac apparent diffusion
coefficient and fractional anisotropy in healthy volunteers
The authors validated a stimulated-echo diffusion tensor
imaging (DTI) sequence using phantoms and assessed
its reproducibility between two CMR centres at 3 T [40].
The same ten healthy volunteers were scanned using the
DT-CMR sequence at the two centres less than 7 days
apart and the apparent diffusion coefficient (ADC) and
fractional anisotropy (FA) were calculated in a single
mid-ventricular, short axis slice. Systolic ADC, systolic
FA and diastolic FA were similar and only the diastolic
ADC showed a statistically significant, but numerically
small, difference between centres. The intercentre, intra-
subject coefficients of variance were: systolic ADC 7 %,
FA 6 %; diastolic ADC 7 %, FA 3 %.
Atheroma, vascular, aorta, valves
Beside its key role in research, CMR is most frequently
used clinically for the carotid arteries where it can be
used to characterize thrombus, [41] plaque compo-
nents, [42] plaque vulnerability, atheroma burden, nat-
ural history of progression, and response to treatment.
However, peripheral artery angiography, [43–45] and
the role in investigation of pulmonary hypertension,
[46] vasculitis and systemic hypertension, [47] is also
making progress. This is an area of CMR where con-
trast agents, [48] and 3 T has had an impact [49, 50].
CMR is widely used for assessment of the aorta in both
congenital, [51] genetic, [52] and acquired conditions
and is particularly well suited longitudinal follow-up of
aortic dimensions, [53] and more complex aspects of
aortic function, [54] such as pulse wave velocity, [55]
distensibility and shear stress [56]. The design of arter-
ial phantoms has proved useful for modelling [57]. The
application of CMR to the assessment of valvular heart
disease continues to increase, [58] particularly in aortic
stenosis [59–61]. This is in part due to greater appreci-
ation of its complementary roles in relation to echocardi-
ography, which is commonly the first line investigative
technique.
Feasibility study of electrocardiographic and respiratory
gated, gadolinium enhanced magnetic resonance
angiography of pulmonary veins and the impact of heart
rate and rhythm on study quality
Three dimensional respiratory and end systolic ECG
gated, gadolinium enhanced magnetic resonance angi-
ography was performed on a 3 Tesla (3 T) scanner in
101 consecutive patients, 35 of them in AF, prior to
ablation [62]. Image and segmentation quality were
scored. All studies except one (99 %) were considered
diagnostic, 91 of them (90.1 %) being of good or ex-
cellent quality. Quality was not found to depend on
heart rate or rhythm for this free breathing, radiation
free strategy, which offers an alternative to current
MRA or CT based approaches.
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Accelerated free breathing ECG triggered contrast
enhanced pulmonary vein magnetic resonance
angiography using compressed sensing
This is a feasibility study assessing an accelerated
electrocardiogram-triggered contrast enhanced pulmonary
vein MRA with isotropic spatial resolution, compressed
sensing and respiratory navigator to define pulmonary
venous anatomy prior PV ablation for atrial fibrillation
in 19 patients and compared with the conventional
breath-hold first pass non-ECG triggered CE-MRA
[63]. The authors showed that the new technique pro-
vides an improved PVs sharpness compared to conven-
tional technique and may be a considered as an alternative
in patients in which the first pass CE-PV MRA fails due to
inaccurate first pass timing or inability of the patient to
perform a 20–25 s breath-hold. Important limitations of
this study includes: small patient population, signal to
noise ratio and contrast to noise ratio were not assessed
and the benefit of the proposed approach for the planning
and guidance of PVI procedures as well as the detection of
potential post-procedural complications was not evaluated.
Computed tomography angiography vs 3 T black-blood
cardiovascular magnetic resonance for identification of
symptomatic carotid plaques
This was a head-to-head comparison between Multi-
detector Computed Tomography Angiography (MDCTA)
and black-blood 3 T-cardiovascular magnetic resonance
(bb-CMR) with respect to their ability to identify symp-
tomatic carotid plaques characteristics [64]. Twenty-two
stroke unit patients with unilateral symptomatic carotid
disease and >50 % stenosis by duplex ultrasound were
studied within 15 days of symptom onset. Both symptom-
atic and contralateral asymptomatic sides were evaluated.
Bb-CMR was shown to be superior to MDCTA at identi-
fying symptomatic carotid plaques, while MDCTA offers
high specificity at the cost of low sensitivity. Results
were only slightly improved over bb-CMR alone when
combining both techniques. The study design, however,
is cross sectional examining patients symptomatic pa-
tients and does not assess plaque characteristics regarding
the risk of future cerebrovascular events. In addition the
MDCTA examination parameters were not identical and
this may have accounted for possible differences by apply-
ing a uniform image quality score to all images. Other
limitation is contrast enhanced MRA was not used which
might have increased the sensitivity of CMR to detect sur-
face irregularities in carotid plaques.
High resolution 3D diffusion cardiovascular magnetic
resonance of carotid vessel wall to detect lipid core
without contrast media
This mainly technical work aims to develop a diffusion-
prepared turbo-spin-echo (DP-TSE) technique for carotid
plaque characterization with 3D high resolution and
improved image quality and applied to 15 healthy vol-
unteers and six patients with carotid artery disease
[65]. In this preliminary study the authors diffusion-
prepared CMR allows 3D DWI of the carotid arterial
wall in vivo with high spatial resolution and improved
image quality. It can potentially detect lipid rich nec-
rotic core without the use of contrast agents.
HIV is an independent predictor of aortic stiffness
Cardiovascular events and cardiovascular related mor-
tality increased in HIV-infected patients treated with ef-
fective antiretroviral therapy [66]. Identifying those at
higher cardiovascular risk is therefore of great clinical
importance. This study showed that, after matching for
potential confounders, HIV infection is independently
associated with increased aortic PWV and decreased
aortic distensibility measured by CMR, both sensitive
markers of reduced aortic elastic function. In addition
HIV infection is an independent predictor of both in-
creased pulse wave velocity and decreased aortic disten-
sibility, clinical measures of aortic stiffness linked to
increased cardiovascular mortality. The size of this det-
rimental effect is similar to that seen with the metabolic
syndrome, a powerful cardiovascular risk factor. The
authors showed that HIV and the metabolic syndrome
are additive in their negative effects on PWV and aortic
distensibility, suggesting that both are risk factors that
act in different ways to impair vascular elasticity. The
mechanism of vascular alterations in patients with HIV
may be secondary to direct effects of the HIV virus on
vascular function, including direct alteration in endo-
thelial function, inflammation, and modification of aor-
tic wall vascular smooth muscle cell behaviour and
extra-cellular matrix composition. Due to the observa-
tional nature of this study, it is not possible to confirm
causality or mechanisms which might underlie the in-
creased aortic PWV and decreased aortic distensibility
in patients with HIV. The study was also not powered
to detect differences in HAART-naïve and treated sub-
jects. Nor was it possible to determine the effects of indi-
vidual anti-retroviral medications on vascular function.
Optimization of Improved Motion-sensitized
Driven-equilibrium (iMSDE) blood suppression for
carotid artery wall imaging
Authors investigate the signal to noise ratio (SNR) and
blood suppression performance of improved motion-
sensitized driven-equilibrium (iMSDE) preparations tech-
nique for carotid wall imaging using composite RF pulses
and sinusoidal gradients [67]. Twelve healthy volunteers
and six patients with carotid artery disease underwent
iMSDE and double inversion recovery (DIR) prepared
T1- and T2-w fast spin echo (FSE) of the carotid
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arteries. iMSDE preparation achieved better blood sup-
pression than DIR preparation with reduced vessel wall
CNR efficiency in T1-w and T2-w images. However, SNR
is significantly reduced and the patients population stud-
ied is extremely small.
Scan-rescan reproducibility of quantitative assessment of
inflammatory carotid atherosclerotic plaque using dynamic
contrast-enhanced 3 T CMR in a multi-center study
Atheromatous plaques neovascularization and inflam-
mation are associated with clinical cardiovascular events.
Detection and quantification of neovascularization and
inflammation in-vivo are important. This study aims to
investigate the inter-scan reproducibility of kinetic param-
eters in atherosclerotic plaque using dynamic contrast-
enhanced (DCE) CMR in a multi-center setting using
3 T field strength [68]. Study result indicates that quan-
titative measurement from DCE-CMR is feasible to de-
tect changes with a relatively modest sample size in a
prospective multi-center study despite the limitations.
The relative high dropout rate suggested the critical needs
for intensive operator training, optimized imaging proto-
col, and strict quality control in future studies.
Multi-contrast atherosclerosis characterization (MATCH)
of carotid plaque with a single 5-min scan: technical
development and clinical feasibility
A 3D CMR technique using Multi-contrast Athero-
sclerosis Characterization (MATCH) was developed to
address some aspects of CMR limitation in this field
including low slice resolution, long scan time, image
mis-registration, and complex image interpretation [69].
The advantage of MATCH is it provides spatially co-
registered multi-contrast image sets in a single scan for
characterization of carotid plaque composition. As the
authors acknowledge there are several important limita-
tions of this study including no provision of plaque
histology and the extremely limited patient sample size,
six patients only.
Cardiovascular outcome associations among cardiovascular
magnetic resonance measures of arterial stiffness: the
Dallas heart study
The purpose of this study was to evaluate associations of
CMR measures of total arterial compliance and two
CMR measures of aortic stiffness with respect to future
cardiovascular events in 2122 Dallas Heart Study partici-
pants without cardiovascular disease [70]. Study results
showed that total arterial compliance and aortic distensi-
bility may be stronger predictors of nonfatal cardiac
events, while pulse wave velocity may be a stronger pre-
dictor of nonfatal extra-cardiac vascular events. Import-
ant limitations of this study include: non-invasive
measurement of peripheral blood pressure to calculate
aortic compliance and distensibility and the limited
number of adverse events throughout the surveillance
period limited the statistical power to explore associa-
tions with event subtypes and within subgroups.
Robust volume-targeted balanced steady-state
free-precession coronary magnetic resonance angiography
in a breathhold at 3.0 Tesla: a reproducibility study
The purpose of this work was to refine, implement,
and test a robust, practical single-breathhold bSSFP
coronary MRA sequence at 3.0 T and to test the re-
producibility of the technique [71]. Results showed that
the 3D bSSFP acquisition, using a state-of-the-art MR
scanner equipped with recently available technologies
such as multi-transmit, 32-channel cardiac coil, and local-
ized B0 and B1+ shimming, allows accelerated and repro-
ducible multi-segment assessment of the major coronary
arteries at 3 T in a single breathhold. The study is limited
by small patient population (three patients with coronary
artery disease and 15 healthy volunteers) and the imaging
sequence was not evaluated in both the right and left cor-
onary systems in every volunteer.
Imaging of carotid artery vessel wall edema using
T2-weighted cardiovascular magnetic resonance
The ability of novel 3D T2W black-blood imaging se-
quence to detect oedema induced in porcine carotid
arteries by acute balloon injury compared to conven-
tional 2D T2-weighted black-blood CMR was investi-
gated in a porcine model [72]. The novel 3D imaging
sequences and T2prep-GE perform comparably to
conventional 2D T2-STIR in terms of detecting vessel
wall edema. The improved spatial coverage of these
3D sequences may facilitate visualization of vessel wall
edema to enable detection and monitoring of vulnerable
carotid atherosclerotic plaques. A valid critique is that the
balloon injury may cause more edema than there will be
present in an atherosclerotic plaque although even very
subtle injury to the vessel caused by pulling back the de-
flated balloon was reliably detected by CMR in accordance
with macroscopical uptake by means of Evans Blue dye
that only enters the injured vessel wall.
Observational study of regional aortic size referenced to
body size: production of a cardiovascular magnetic
resonance nomogram
CMR is regarded the standard of reference for clinical
assessment of the aorta, but normal CMR dimensions in
large size population study are not available. The aim of
this study is to produce a normal CMR reference range
of aortic diameters and to investigate the relationship
between regional aortic size and body surface area (BSA)
in a large group of healthy subjects with no vascular risk
factors [73]. A normal CMR reference range for BSA
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normalized aortic diameters, correlated to age at six
points along the aorta were presented. Across both gen-
ders, increasing body size is characterized by a modest
degree of aortic dilatation, even in the absence of trad-
itional cardiovascular risk factors.
Feasibility of asymmetric stretch assessment in the
ascending aortic wall with DENSE cardiovascular
magnetic resonance
The objective of this feasibility study is to investigate
the feasibility of assessing asymmetric stretch in healthy
and diseased ascending aortas using Displacement En-
coding with Stimulated Echoes (DENSE) [74]. Fifteen
patients with congenital aortic valve disease or aortic
dilation and five healthy volunteers were studied. The
study showed that evaluation of asymmetric stretch is
feasible in the ascending aorta with DENSE CMR. Clear
differences in stretch are seen between patients and vol-
unteers, with asymmetric patterns demonstrated around
the aortic circumference.
Non-invasive imaging of carotid arterial restenosis using
3 T cardiovascular magnetic resonance
This study investigated the ability of 3 T CMR to de-
termine the components of recurrent carotid artery dis-
ease and examined whether these differed from primary
atherosclerotic plaque [75]. Twenty-five patients with
previous carotid endarterectomy and 25 with primary
asymptomatic atherosclerotic plaques serving as con-
trols were studied. Two experienced reviewers ana-
lysed the multicontrast CMR images according to the
presence or absence of major plaque features and
assigned an overall classification type. As defined by
CMR, restenotic lesions of the carotid artery fall into
three distinct types and differ in composition from pri-
mary atherosclerotic plaques. If validated by subsequent
histological studies, these findings could suggest a role
for CMR in detecting high-risk (i.e. lipid-rich) reste-
notic lesions.
The role of cardiovascular magnetic resonance in
stratifying paravalvular leak severity after transcatheter
aortic valve replacement: an observational outcome study
Paravalular leak (PVL) is common post transcatheter
aortic valve implantation (TAVI). A population of pa-
tients post TAVI underwent CMR and echocardio-
graphic assessment of the aortic valve for PVL [76].
Severity of PVL was greater when quantified using
CMR compared to echocardiography. On follow up,
48 % of patients reached the primary endpoint of all
cause death, heart failure hospitalisation and intract-
able symptoms requiring repeat invasive therapy. PVL
with a regurgitant fraction >20 % was associated with
reduced event free survival and CMR provided superior
prognostic value compared to both quantitative and semi-
quantitative echocardiographic assessment.
Feature tracking
Measuring cardiac function is a fundamental for CMR.
Myocardial tagging remains a source of research, [77]
and at 3 T has attracted interest, partly because of the
improved tag persistence with longer T1. Newer tech-
niques have also been reported in humans, including myo-
cardial velocity encoding, [78–80] and DENSE [81, 82].
Feature tracking has become an area of active interest
with development of simple to use software that can
be used post-hoc on simple cines [83, 84]. The papers
below pursue novel aspects of cardiac function.
Feature tracking compared with tissue tagging
measurements of segmental strain by cardiovascular
magnetic resonance
In this study, the CMR cine images of ten healthy
volunteers, ten patients with left bundle branch block
and ten with hypertrophic cardiomyopathy, who had
also had CMR tissue tagging performed, were ana-
lysed by feature tracking (FT) of both the endocardial
and mid wall circumferences in short axis planes [85].
The intra and inter-observer agreements of segmental
peak systolic circumferential strain and time to peak
systolic circumferential strain were substantially lower
for feature tracking than tagging, leading to the con-
clusion that, although convenient, the feature tracking
techniques used were less suitable than the tagging
for clinical or research purposes.
Biventricular myocardial strain analysis in patients with
arrhythmogenic right ventricular cardiomyopathy (ARVC)
using cardiovascular magnetic resonance feature tracking
This study aimed to examine whether CMR based
strain analysis using feature tracking (FT) could serve
as a quantifiable measure to confirm global and re-
gional ventricular dysfunction in ARVC patients and so
support the early detection of ARVC [86]. Groups studied
were 20 with ARVC, 30 with borderline ARVC, 22
with a positive family history but no manifest ARVC
and ten healthy volunteers. Strain analysis by FT was
found to differentiate between manifest or borderline
ARVC and the healthy volunteers HV, even when
ejection fraction was normal.
Quantification of left atrial strain and strain rate using
Cardiovascular Magnetic Resonance myocardial feature
tracking: a feasibility study
Myocardial feature tracking (FT) was applied to the
SSFP long axis cine images of ten healthy volunteers, ten
patients with hypertrophic cardiomyopathy (HCM) and
ten with heart failure and preserved ejection fraction
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(HFpEF) to quantify left atrial deformation [87]. Evi-
dence of impaired LA reservoir function was found in
HCM and HFpEF relative to that of volunteers suggest-
ing that this novel approach has potential value for the
quantification of atrial performance.
Value of additional strain analysis with feature tracking in
dobutamine stress cardiovascular magnetic resonance for
detecting coronary artery disease
This study assessed the value of feature tracking for as-
sessment of myocardial ischaemia [88]. Circumferential
strain of the LV (Fcc) was measured during Dobuta-
mine stress CMR (DS-CMR) in a population of 25 pa-
tients with known or suspected coronary artery disease
and normal resting left ventricular function. There was
no difference in Fcc between myocardial segments sup-
plied by unobstructed coronary arteries (defined angio-
graphically) and those supplied by significantly stenosed
arteries at rest, however there was a significant difference
between the two groups following Dobutamine infusion.
Using angiography as the gold standard, Fcc during Dobu-
tamine differentiated normal from stenotic segments with
a sensitivity of 75 %, a specificity of 67 % and an area
under the curve of 0.78.
Cardiomyopathy
The phenotyping of cardiomyopathy is a primary clin-
ical indication for CMR, and has become mainstream
in hypertrophic cardiomyopathy. Recent attention has
been focussed on T1 imaging, [89, 90] with standard-
isation of T1 acquisition, [91–93] technical develop-
ments, [94–96] and the assessment of diffuse fibrosis
in cardiomyopathy [97]. Significant progress has been
made in a wide range of unusual conditions including
muscular dystrophy, [98–100] ARVC, [101] systemic
sclerosis, [102] cardiac related cardiac dysfunction, [103]
non-compaction, [104, 105] and iron loading [106–109].
Prevalence of myocardial crypts in a large retrospective
cohort study by cardiovascular magnetic resonance
Recent reports suggest that crypts, meaning discrete
clefts or fissures in the myocardium of the left ventricle
(LV), usually inferobasal, are prevalent in phenotypically
positive or negative carriers of genes associated with
hypertrophic cardiomyopathy (HCM). However, the retro-
spective study by Child et al. of 1020 consecutive patients
or volunteers who had undergone CMR during a 12-
month period also identified crypts in healthy controls
(11/306, 3.6 %), there being crypts identified in 64 (6.3 %)
of all of the 1020 CMR studies [110]. Crypts were more
prevalent in non-ischaemic cardiomyopathy subgroups
(9/76, 11.7 %, in patients with HCM and 3/11, 27 %,
in those with hypertensive cardiomyopathy). They were
also more prevalent in those referred for CMR for family
screening of inherited forms of cardiomyopathy (10/41,
23 %), although the prognostic significance of crypts in
such individuals remains uncertain until prospective
studies of sufficient numbers have been performed
and analysed.
Population-based studies of myocardial hypertrophy:
high resolution cardiovascular magnetic resonance
atlases improve statistical power
In this study, LV short-axis cine images were acquired
in 138 healthy volunteers using standard 2D imaging
and 3D high spatial resolution CMR [111]. A multi-
atlas technique was used to segment and co-register
each image. High spatial resolution CMR with auto-
mated phenotyping provides greater power for mapping
wall thickness than conventional 2D imaging, enabling
a reduction in the sample size required for studies of
environmental and genetic determinants of LV wall
thickness.
Reproducibility of native myocardial T1 mapping in the
assessment of Fabry disease and its role in early detection
of cardiac involvement by cardiovascular magnetic
resonance
Native T1 mapping was assessed using MOLLI and
ShMOLLI sequences at 1.5 T in 63 patients with
genetically-confirmed Fabry disease, 25 of whom did not
have left ventricular hypertrophy (LVH) [112]. Native T1
was lowest in the cohort of Fabry’s with LVH, then
Fabry’s without LVH then the control population. The
technique showed high inter- and intra-observer agree-
ment. Reduced native myocardial T1 was associated with
reduced global longitudinal strain on echocardiographic
speckle tracking and increased E/E’, indicating it may
underlie early diastolic dysfunction in Fabry’s.
Reference values for healthy human myocardium using a
T1 mapping methodology: results from the International
T1 Multicenter cardiovascular magnetic resonance study
This trial determined the reference range for T1 map-
ping through study of healthy controls and low risk sub-
jects using a standardized sequence (MOLLI, scheme
3(3)3(3)5)) on 1.5 and 3 T Phillips platforms across mul-
tiple hospital sites [113]. There was close agreement be-
tween T1 values obtained in the core lab and locally for
all sites. Inter and intra operator reproducibility was ex-
cellent for native septal T1. Native T1 values appeared
more reproducible than post-contrast T1 values.
Accuracy and reproducibility of semi-automated late
gadolinium enhancement quantification techniques in
patients with hypertrophic cardiomyopathy
The group compared semi-automated LGE quantification
techniques using manual segmentation as the reference
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standard in a cohort of 76 HCM patients [114]. Quanti-
fication was performed using full width half maximum
(FWHM), signal threshold reference mean (STRM) and
Otsu-auto-threshold (OAT). STRM > 3 standard devia-
tions (SD) showed the greatest agreement with manual
segmentation, however FWHM had the greatest inter-
operator reproducibility. STRM > 5SD, 6SD and FWHM
systematically underestimated total LGE volume com-
pared to manual segmentation
Cardiovascular magnetic resonance characterization of
left ventricular non-compaction provides independent
prognostic information in patients with incident heart
failure or suspected cardiomyopathy
Patients with incident heart failure or suspected car-
diomyopathy in whom CMR yielded a diagnosis of LV
non compaction were followed for a mean of 27 months
[115]. On multivariate analysis, the incidence of tachyar-
rhythmias (atrial and ventricular) was significantly greater
in patients with LGE compared to those without LGE,
even when adjusted for LV and RV ejection fraction.
Left ventricular systolic function and the pattern of
late-gadolinium-enhancement independently and additively
predict adverse cardiac events in muscular dystrophy
patients
Florian assessed 88 patients with Duchenne and Becker
muscular dystrophies with CMR and followed them for
a 47+/−18 months [116]. During this time there were
three deaths, eight heart-failure hospitalisations and 13
episodes of non-sustained ventricular tachycardia. On
multivariate analysis, LVEF and the presence of trans-
mural LGE were the only independent predictors of
hospitalization/non sustained ventricular tachycardia.
Coronary microvascular ischemia in hypertrophic
cardiomyopathy - a pixel-wise quantitative cardiovascular
magnetic resonance perfusion study
The group used CMR first pass myocardial perfusion
to perform pixel wise quantitative perfusion analysis
in 35 HCM patients [117]. Myocardial blood flow was
significantly higher in the LV endocardium compared
to the epicardium at rest and this reversed following
administration of adenosine. Segmental analysis re-
vealed that 31 % of patients had stress myocardial
perfusion values lower than rest perfusion, indicating
regions of myocardial ischaemia. These were more
common in regions with a greater wall thickness and
more replacement fibrosis.
Myocardial fibrosis in patients with myotonic dystrophy
type 1: a cardiovascular magnetic resonance study
Myotonic dystrophy type 1 (DM1) is associated with in-
creased cardiac morbidity and mortality. This CMR study
of 30 DM1 patients revealed a high prevalence of myo-
cardial fibrosis (40 %), most commonly of the RV inser-
tion points and with a heterogenous distribution within
the LV myocardium [118]. Presence of LGE was not
predicted by ECG, Holter-monitoring or echocardiog-
raphy. CMR for screening is additive to current stand-
ard cardiac assessment and may prove to be a clinically
valuable tool for risk stratification in DM1.
Patterns of late gadolinium enhancement in Duchenne
muscular dystrophy carriers
Thirty carriers of the Duchenne muscular dystrophy
(DMD) mutation were compared to gender and age
matched controls [119]. A typical myocardial LGE-
pattern location, localized to LV segments five and six
was commonly seen in DMD carriers. LGE was more
frequently subepicardial plus mid-myocardial in symp-
tomatic carriers, despite normal LV systolic and diastolic
function. No genotype-phenotype correlation was found.
Effect of the 2010 task force criteria on reclassification
of cardiovascular magnetic resonance criteria for
arrhythmogenic right ventricular cardiomyopathy
Liu et al. evaluated the effect of the use of the revised
2010 Task Force Criteria for the diagnosis of ARVC
through retrospective review of 968 consecutive patients
referred for CMR with clinical suspicion of ARVC be-
tween 1995 and 2010 [120]. Application of the 2010 cri-
teria resulted in reduction in the number of patients
meeting CMR criteria for diagnosis from 22.7 to 2.6 %
compared to the 1994 criteria.
Arrhythmogenic right ventricular cardiomyopathy (ARVC):
cardiovascular magnetic resonance update
This highly accessed Review article provides an update
of Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC), its diagnostic criteria, implicated genes, CMR
evaluation and current management considerations
[121]. ARVC is a common cause of sudden death in the
young. CMR provides accurate measurement of RV vol-
umes, a key criterion in the revised Task Force criteria
as well as detailed characterization of cardiac morph-
ology, function and tissue characterization. Pathogenic
mutations in the cardiac desmosome are found in ap-
proximately 60 % of index patients and left ventricular
involvement is increasingly recognized.
A novel and practical cardiovascular magnetic resonance
method to quantify mitral annular excursion and recoil
applied to hypertrophic cardiomyopathy
This proof of concept paper described a novel CMR tech-
nique to evaluate mitral annual motion through tracking
of the atrioventricular junction (AVJ) [122]. This was
tested through retrospective analysis of 24 HCM and 14
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healthy volunteers. The tracking feature allowed calcu-
lation of the maximum AVJ displacement during the
cardiac cycle, the velocity of the mitral annulus during
early diastole and in diastasis. HCM patients demon-
strated significant reduction in mitral annual excursion
compared to controls.
In-vivo T1 cardiovascular magnetic resonance study of
diffuse myocardial fibrosis in hypertrophic cardiomyopathy
Brouwer et al. compared T1 mapping derived ECV, ac-
quired using a MOLLI sequence, in HCM and healthy
controls [123]. Areas of LGE enhancement were ex-
cluded. There was no difference in ECV in HCM com-
pared to controls for the regions of myocardium without
LGE. The authors concluded that the additional clinical
value of T1 mapping in HCM appeared limited.
Radiation recall reaction causing cardiotoxicity
The authors describe the imaging findings of radi-
ation recall reaction causing cardiotoxicity [124]. The
patient had prior mediastinal radiotherapy and pre-
sented 5 months later with impaired ejection fraction
after chemotherapy. CMR demonstrated regional myo-
cardial edema on T2 weighted sequences and LGE in
the same area.
Subclinical myocardial inflammation and diffuse fibrosis
are common in systemic sclerosis – a clinical study using
myocardial T1-mapping and extracellular volume
quantification
CMR was performed in 19 patients with systemic
sclerosis and 20 controls at 1.5 T with cine imaging,
tagging, T1-mapping, STIR, LGE imaging and ECV
quantification [125]. Cardiac involvement was com-
mon, even in the absence of cardiac symptoms. 53 %
of systemic sclerosis patients had LGE enhancement
and focal areas of myocardial oedema on STIR im-
aging. The ECV was expanded, likely representing a
combination of low-grade inflammation and diffuse myo-
cardial fibrosis, and correlated with disease activity.
Long term effects of cocaine on the heart assessed by
cardiovascular magnetic resonance at 3 T
Ninety-four consecutive asymptomatic cocaine users
with a mean duration of 14+/−9 years of drug use
underwent CMR [126]. Compared to an age-matched
healthy cohort, the cocaine abusers had increased LV
end-systolic volume, LV mass index and RV end-systolic
volume, with decreased LVEF and RVEF. No subject
had myocardial oedema, but 30 % had myocardial
LGE indicating myocardial damage. Duration of co-
caine abuse was related to probability of LV systolic
dysfunction.
Mapping iron in human heart tissue with synchrotron
x-ray fluorescence microscopy and cardiovascular magnetic
resonance
This ex-vivo case study compared synchrotron X-ray
fluorescence microscopy (XFM) elemental iron maps
with magnetic resonance transverse relaxation rate maps
of cardiac tissue samples from an iron-loaded patient
with Diamond Blackfan anaemia [127]. This allowed
comparison of macroscopic iron distribution within the
heart with a high spatial resolution and comparison with
regional T2* values using CMR. There was close qualita-
tive and quantitative agreement between the synchrotron
XFM iron maps and MR relaxometry maps. Iron ap-
peared to preferentially load into the lateral epicardium
wall and there was a strong gradient of decreasing iron,
T2 and T2* relaxation properties from the epicardium to
the endocardium.
Calibration of myocardial T2 and T1 against iron
concentration
Ex-vivo iron loaded hearts were studied using R1 and R2
measurements (R1 = 1/T1 and R2 = 1/T2) at 1.5 Tesla
and compared with myocardial iron concentration calcu-
lated using inductively coupled plasma atomic emission
spectroscopy [128]. There was a strong correlation be-
tween LnR2 and Ln[Fe] suggesting that T2 may provide
additive information to T2* in myocardial siderosis. Ex-
vivo T1 measurements were strongly affected by forma-
lin and the authors conclude that T1 calibration may
only be practical in-vivo or non-formalinised specimens.
Biopsy-based calibration of T2* magnetic resonance for
estimation of liver iron concentration and comparison
with R2 Ferriscan
Liver iron concentration studies based on early T2* se-
quences were limited by a requirement for short echo
times [129]. MR technology has since improved as has
estimation of iron concentration on biopsy. The group
performed a calibration study of a contemporary state of
the start liver optimized T2* sequence using 50 iron-
loaded liver biopsy specimens. There was a strong linear
correlation between ln(T2*) and ln(LIC). The contem-
porary method yielded liver iron concentration values
2.2 times higher compared to the original proof of con-
cept T2* values. Inter-observer agreement was excellent.
Animal studies and MR spectroscopy
The use of animals to study cardiac physiology and me-
tabolism continues to contribute a small but important
section to the journal, often using MR spectroscopy,
[130] and high field magnets, [131] and investigating
novel ideas [132].
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Endogenous assessment of chronic myocardial infarction
with T1ρ-mapping in patients
The longitudinal relaxation time in the rotating frame
(T1ρ) is a tissue marker to non-invasively measure colla-
gen content, and may have the potential to detect fibro-
sis in the hearts of patients with chronic myocardial
infarction (MI) without the need of exogenous contrast
agents [133]. This paper demonstrates the feasibility of
native T1ρ-mapping for the detection of myocardial fi-
brosis in the clinical setting using a large animal model,
and translates this technique into patients with chronic
MI. While significantly higher T1ρ –values were found in
the infarct tissue of MI patients compared to the remote
zone, the sensitivity of detecting the injury was lower
compared to the gold-standard late gadolinium enhance-
ment (LGE) CMR. This work opens a new avenue for
non-invasive tissue characterization and further work is
required to improve sensitivity and specificity of this
technique.
A high-resolution cardiovascular magnetic resonance
diffusion tensor map from ex-vivo C57BL/6 murine hearts
The complex cardiac micro-structure and spatial ar-
rangement of cardiomyocytes in laminar sheetlets is
important for normal function of the heart. Cardiac
diffusion tensor imaging (CDTI) of hearts ex vivo allows
for a more detailed and comprehensive characterization of
the myocardial architecture. In this study, high-resolution
CDTI was combined with statistical tensor analysis to ob-
tain an average description (i.e. atlas) of the fiber architec-
ture in fixed mouse hearts [134]. The excellent spatial
resolution and the high-signal-to-noise ratio of the data
resulted in low variability of local myocyte orientation,
leading also to the suggestion that hearts of mice are more
structured than those of larger mammalians (including
humans). This work represents a baseline of CDTI indices
in mice, and may help to improve detection of bio-
markers, particularly in disease states or following genetic
modifications.
Quantitative assessment of magnetic resonance derived
myocardial perfusion measurements using advanced
techniques: microsphere validation in an explanted pig
heart system
This paper reports on the validation of quantitative car-
diovascular Magnetic Resonance (CMR) myocardial per-
fusion imaging against fluorescently-labeled microspheres
on an isolated perfused pig heart model in order to deter-
mine the accuracy of available algorithms for the quantifi-
cation of myocardial blood flow (MBF) [135]. Perfusion
images were acquired at 1.5 and 3 T at different perfusion
states resembling physiological and reduced flow, during
adenosine-induced hyperaemia and during coronary occlu-
sion, respectively. The administration of the fluorescently-
labeled microspheres and externally controlled coronary
blood flow served as reference standards. It was found that
the analysis based on the Fermi function deconvolution
achieved the highest accuracy and best correlation at both
field strengths, and may thus serve as the clinical tool pro-
viding accurate quantitative blood flow assessment.
Myocardial perfusion and oxygenation are impaired during
stress in severe aortic stenosis and correlate with impaired
energetics and subclinical left ventricular dysfunction
A comprehensive, multi-parametric CMR protocol, in-
cluding cine-MRI, tagging, BOLD, stress-perfusion and
31P-MRS was used to address the question whether or
not reduced myocardial perfusion reserve observed in
patients with left-ventricular hypertrophy due to aortic
stenosis (AS) but without obstructive coronary artery
disease leads to tissue deoxygenation [136]. This study
found a blunted oxygenation response to adenosine
stress in this patient group, which is suggestive of micro-
vascular impairment. Both BOLD response and myocar-
dial perfusion reserve index correlated with impaired
energetics and subclinical LV dysfunction. Importantly,
myocardial perfusion, oxygenation, energetics and con-
tractility were restored following aortic valve replace-
ment. This work nicely illustrates the strength of CMR
in diagnosing and aiding novel therapeutic strategies in
AS patients.
Non-invasive assessment of cardiac function and
pulmonary vascular resistance in a canine model of acute
thromboembolic pulmonary hypertension using 4D flow
cardiovascular magnetic resonance
This study sought to simultaneously quantify cardiac func-
tion and cardiopulmonary hemodynamic parameters from
a free-breathing 4D (time-resolved three-directionally mo-
tion encoded) flow CMR examination in a canine model
of acute thromboembolic pulmonary hypertension (PH)
[137]. The accelerated 4D-technique allowed for the as-
sessment of left- and right-ventricular functional indices
in agreement with conventional 2D cine SSFP-derived
values, while providing a comprehensive characterization
of pulmonary artery and aortic flow, and tricuspid
valve regurgitation velocity. However, this work dem-
onstrates only feasibility in a small sample size, and
does not validate the model in a separate cohort as
acknowledged by the authors. Future work is required
to investigate if these results are transferable to other
etiologies of PH and/or humans.
In vivo characterization of rodent cyclic myocardial
perfusion variation at rest and during adenosine-induced
stress using cine-ASL cardiovascular magnetic resonance
In this study, arterial spin labeling (ASL)-cine MRI was
used to quantify variations in myocardial blood flow
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during a cardiac cycle in healthy rats [138]. The authors
demonstrated a significant increase in MBF from end-
systole to end-diastole in both rest and adenosine-
induced stress conditions. These findings are in contrast
to a previous study in humans, [139] which only re-
ported differences in MBF under stress conditions but
not at rest. Improved precision in the here presented
small-animal study, which did not rely on a first-pass
gadolinium-based MRI technique, may explain this
discrepancy. The authors conclude that this technique
may be useful to study microvascular defects in ro-
dent models of non-ischemic heart disease.
Chronic diuretic therapy attenuates renal BOLD magnetic
resonance response to an acute furosemide stimulus
In this study, BOLD imaging was used in patients with
renal artery stenosis (RAS) to characterize increases in
renal oxygenation, as a marker of kidney viability, fol-
lowing the administration of a standard 20 mg intra-
venous furosemide stimulus [140]. In particular, it was
shown that a chronic loop diuretic therapy attenuates
the BOLD MR responses to an acute furosemide stimu-
lus. This has significant implications for the evaluation
of RAS patients being for renal artery revascularization
procedures, suggesting that a different dosing strategy
is required before BOLD MR can be widely used to de-
termine renal viability.
Left ventricular mass and function
Although it is possible to get diagnostic images in the
majority of patients referred for CMR, image quality can
be compromised by patient difficulty performing breath
holds and also by arrhythmia. We have received a num-
ber of papers validating sequences aimed at overcoming
difficulties, [141] and also reducing scan duration with
benefit for both patients and workflow. Use of acceler-
ated real-time data is one such approach to this prob-
lem, as it can reduce or eliminate the requirement for
ECG gating and breathholding [142, 143]. There is also
continued interest in novel analysis techniques, [144]
novel areas, [145] reference ranges, [146] and atlas based
studies for description of function for populations [147].
Evaluation of left ventricular ejection fraction using
through-time radial GRAPPA
In this paper, the authors determined LV volumes and
LVEF using a free breathing real-time radial GRAPPA
sequence at 1.5 T in 63 subjects comparing results to a
standard breath-hold SSFP sequence [148]. The differ-
ences in EF, EDV, and ESV between the gold-standard
and real-time methods were not statistically significant
(p-values of 0.77, 0.82, and 0.97, respectively). Although
there is a relatively lengthy calibration phase required
for this technique, the scan time was significantly
shorter for the highly accelerated real-time data collec-
tion (p < 0.001) and fewer artifacts were reported in the
real-time images (p < 0.01). In the qualitative image ana-
lysis, reviewers marginally preferred the standard images
although some features including cardiac motion were
equivalently rated. The authors suggest that real-time
functional CMR with through-time radial GRAPPA per-
formed without ECG-gating under free-breathing can be
considered as an alternative to gold-standard breathhold
cine imaging for the evaluation of ejection fraction. As
such, this can now be further evaluated in the more
challenging groups to image.
Quantification of left ventricular functional parameter values
using 3D spiral bSSFP and through-time Non-Cartesian
GRAPPA
The authors presented data on the initial validation of a
novel 3D cine volumetric acquisition using multiple ac-
celeration techniques [149]. A six-fold undersampled 3D
stack of spirals balanced SSFP sequence with 3D
through-time spiral GRAPPA parallel imaging recon-
struction is compared to standard 2D cine imaging at
3 T for quantification of left ventricular EDV, ESV, EF
and ventricular mass in 10 healthy volunteers. The 3D
method demonstrated equivalent systolic left ventricular
functional parameter values, required significantly less
total scan time (48 s including a single 14 s breathhold
compared to an average of 5 min 40 s for the same
coverage by the 2D method) and yielded acceptable
image quality with respect to the 2D segmented multi-
breathhold standard.
Ex vivo cardiovascular magnetic resonance measurements
of right and left ventricular mass compared with direct
mass measurement in excised hearts after transplantation:
a first human SSFP comparison
This study has evaluated ex vivo LV and RV mass CMR
assessment by SSFP sequence in comparison with aut-
opsy mass of hearts from cardiac transplants patients in
a single centre study of 55 explanted cardiomyopathy
hearts which were successfully scanned just after sur-
gery and then weighed by a pathologist [150]. Signifi-
cant positive correlations were found between total 3D
CMR mass (450 ± 111 g) and total pathology mass (445 ±
116 g; r = 0.99, p < 0.001) as well as 3D CMR measured LV
mass (301 ± 93 g) and the pathology measured LV mass
(313 ± 96 g; r = 0.95, p < 0.001). Strong positive correla-
tions were demonstrated between the 3D CMR measured
RV mass (149 ± 46 g) and the pathology measured RV
mass (128 ± 40 g; r = 0.76, p < 0.001). The mean bias be-
tween 3D-CMR and pathology measures for total mass,
LV mass and RV mass were: 3.0, −16 and 19 g, respect-
ively. This paper validates the accuracy of SSFP-CMR
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sequence to determine myocardial mass as a ‘gold
standard’ in humans.
Left ventricular shape variation in asymptomatic
populations: the multi-ethnic study of atherosclerosis
The authors successfully constructed an atlas compris-
ing 1991 CMR cases contributed from the Multi-Ethnic
Study of Atherosclerosis baseline examination. From
this collection of data from asymptomatic adult volun-
teers, they quantified the dominant components of glo-
bal shape variation in sub-cohorts (defined by ethnicity,
sex, smoking, hypertension and diabetes) [151]. The
data and results are available at cardiacatlas.org. After
correction for height, shape distributions were princi-
pally explained by size, sphericity and concentricity,
which are known correlates of adverse outcomes. The
resulting shape components distinguished differences
due to ethnicity and risk factors with greater statistical
power than traditional mass and volume indices. This
work is pertinent for the new generation of population
based studies incorporating CMR, demonstrating the
feasibility of such an analysis pipeline in large scale
studies, and showing the incremental benefit of an atlas
approach over standard analysis techniques.
The influence of pericardial fat upon left ventricular
function in obese females: evidence of a site-specific effect
This paper explores whether the previously reported
association between increased pericardial fat volume
and cardiac dysfunction is due to a systemic process
or due to a direct local interaction. 60 obese females
underwent CMR to assess LV function and pericardial
fat volumes [152]. The authors found that LV fat cor-
related weakly with cardiac output (r = −0.41, p = 0.001)
and stroke volume (r = −0.26, p = 0.05), as well as diastolic
functional parameters including peak-early-filling rate
(r = −0.38, p = 0.01) and early late filling ratio (r = −0.34,
p = 0.03). LV hemodynamic and diastolic function was
associated more with LV fat as compared to RV or
total pericardial fat, but not with systemic inflamma-
tory markers or adipokines. These findings suggest a
site-specific influence of pericardial fat on LV func-
tion, which could imply local secretion of molecules
into the underlying tissue or an anatomic effect.
Diastolic function
The ability of echocardiography to rapidly and robustly
evaluate diastolic function is one of its strengths. Al-
though CMR techniques to reliably assess diastolic func-
tion have existed for many years, numerous methods for
making this more routine within the CMR exam con-
tinue to materialise, [153, 154] often employing custom-
written software and semi-automation. These techniques
can vary from utilising tracking of anatomical features
with time to more complex mathematical and physio-
logical models.
Evaluation of diastolic function by three-dimensional
volume tracking of the mitral annulus with cardiovascular
magnetic resonance: comparison with tissue Doppler
imaging
In this study, the authors evaluate a semi-automated
CMR technique for quantifying global LV diastolic func-
tion, using 3D volume tracking of the mitral annulus
(MA) from conventional 2D cine-CMR images [155].
One hundred and twenty four consecutive patients with
normal ejection fraction underwent both clinically indi-
cated transthoracic echocardiography (TTE) and CMR.
Interpolated 3D reconstruction of the MA over time was
performed with semi-automated atrioventricular junc-
tion (AVJ) tracking in long-axis cine-SSFP images, pro-
ducing an MA sweep volume over the cardiac cycle.
Patients with TTE-based diastolic dysfunction (n = 62)
showed significantly different normalized MA sweep vol-
ume profiles compared to those with TTE-based normal
diastolic function. Good correlations were observed be-
tween CMR early-to-late mitral sweep rate (PSRE/PSRA)
and early-to-late diastolic annular velocity ratios (e’/a’)
measured by TDI (r = 0.756 to 0.828, p < 0.001). 3D MA
sweep volumes generated by semi-automated AVJ
tracking in routinely acquired CMR images yielded dia-
stolic parameters that were effective in identifying pa-
tients with diastolic dysfunction when correlated with
TTE-based variables.
Left ventricular torsion shear angle volume analysis in
patients with hypertension: a global approach for LV
diastolic function
In this paper, the authors propose a novel index for
evaluating LV diastolic function utilizing the LV normal-
ized torsion shear angle volume loop [156]. They evalu-
ated this in 60 resistant hypertension patients (HTN)
and 40 control volunteers studied using CMR with tissue
tagging. The area within the loop was termed the torsion
hysteresis area and was found to be significantly in-
creased (p < 0.001) in the hypertensive patients with con-
centric remodelling compared to controls and also
correlated with E/A (r = 0.23, P = 0.025). The authors
conclude that the normalised torsion shear angle volume
loop incorporates both the active and passive recoil pro-
cesses of LV diastolic and systolic phases, providing a
new global description of LV diastolic function.
Myocarditis
The use of CMR in the diagnosis and assessment of
myocarditis has become commonplace with greater ap-
preciation of the value of LGE and T2W oedema im-
aging in identifying this common but often challenging
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pathology, in addition to the merits of CMR for the as-
sessment of ventricular remodelling.
Cardiovascular magnetic resonance risk stratification in
patients with clinically suspected myocarditis
In this paper, the authors assess the prognostic value of
a normal CMR scan (defined by LV volumes and ejec-
tion fraction and the absence of LGE) in a single centre
cohort of 405 consecutive patients with clinically sus-
pected myocarditis followed up prospectively for median
time of 1591 days [157]. CMR diagnosis was “myocardi-
tis” in 28.8 %, “normal” in 55.6 % and “other pathology”
in 15.6 %. The authors used composite endpoints for
their analyses, while obtaining an overall mortality of
3.2 %. All (7) cardiac deaths and (3) events occurred in
the group with abnormal CMR findings. Kaplan-Meier
analysis showed significant difference for major adverse
cardiac events (cardiac death, sudden cardiac death
(SCD), ICD discharge, aborted SCD) between patients
with normal and abnormal CMR (p = 0.0003). Based on
their data, the authors conclude that patients with sus-
pected myocarditis yet absence of LV dysfunction and
absence of LGE images have a good prognosis independ-
ent of their clinical symptoms and other findings.
Native T1-mapping detects the location, extent and patterns
of acute myocarditis without the need for gadolinium
contrast agents
T1 mapping continues to generate much additional data
with a variety of sequences applied to a widened spectrum
of myocardial pathologies in pursuit of identifying and
demonstrating the areas where this technique has greatest
clinical utility. In this paper, Ferreira et al. study 60 pa-
tients with suspected acute myocarditis and suggest that
their technique based on native T1mapping (ShMOLLI)
can reveal the typical non-ischemic regional patterns of
disease, negating the need for Gadolinium contrast [158].
A threshold of T1 > 990 ms (sensitivity 90 %, specificity
88 %) detected significantly larger areas of involvement
than conventional T2W and LGE imaging in patients, and
additional areas of injury when T2W and LGE were nega-
tive. T1-mapping significantly improved the diagnostic
confidence in an additional 30 % of cases when at least
one of the conventional methods (T2W, LGE) failed to
identify any areas of abnormality. Using incremental
thresholds, T1-mapping can display the non-ischemic pat-
terns of injury typical of myocarditis. Such data may lead
to less routine requirement for the use of Gadolinium
contrast.
Cardiac resynchronisation therapy
The quest for enhanced predictors of response to cardiac
resynchronisation therapy (CRT) and improved benefit
from CRT implantation continues, with significant data
assessing the role of CMR in this field.
Relationship between mechanical dyssynchrony
and intra-operative electrical delay times in patients
undergoing cardiac resynchronization therapy
This study compares mechanical delay times derived
from high temporal resolution short-axis cine CMR data
with intra-operative electrograms recorded at multiple
locations throughout the coronary sinus and its tributar-
ies [159]. The authors found a strong correlation be-
tween electrical and mechanical delay times within each
patient (R2 = 0.78 ± 0.23). They demonstrate that MRI
can potentially be used to prospectively determine the
ideal LV lead location, and show that within the coron-
ary veins, the site of latest mechanical delay is the site of
the latest electrical delay in the majority of patients
(91 %). This study provides initial evidence that non-
invasive mechanical activation patterns derived from
CMR can accurately reflect the underlying electromech-
anical substrate of intraventricular dyssynchrony.
A prospective evaluation of cardiovascular magnetic
resonance measures of dyssynchrony in the prediction
of response to cardiac resynchronization therapy
In this study, the authors establish and then evaluate a
systolic dyssynchrony index (SDI) derived from CMR-
based data as a predictor of response to CRT. SSFP and
CSPAMM images were performed at 1.5 T prior to
CRT and processed using a novel framework to extract
regional ventricular volume-change, thickening and de-
formation fields (strain) [160]. A systolic dyssynchrony
index (SDI) for all parameters within a 16-segment
model of the ventricle was computed with high SDI de-
noting more dyssynchrony. 21 of 44 patients (48 %) re-
cruited in the first phase (mean QRS duration 154 ±
24 ms) patients showed reverse remodelling (RR).
Volume-change SDI was the strongest predictor of RR
(PR 5.67; 95 % CI 1.95–16.5; P = 0.003). SDI derived
from myocardial strain was least predictive. Volume-
change SDI was applied as a predictor of RR to a sec-
ond population of 50 patients (mean QRSd 146 ±
21 ms). When compared to QRSd, LBBB morphology
and scar burden, volume-change SDI was the only sta-
tistically significant predictor of RR in this group. The
authors conclude that volume-change SDI is a highly
reproducible measurement that can be derived from
routinely acquired SSFP cine images and predicts re-
verse remodelling following CRT.
Coronary artery disease
CMR is invaluable to the study of patients with ischaemic
heart disease and has made a major impact on this field
and is now widely used to delineate myocardial infarction,
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[161, 162] and scarring, [163] although more recently
non-contrast techniques to detect infarction have been de-
scribed. The use of techniques to define myocardial
edema, [164–166] myocardium at risk, [167] myocardial
hemorrhage, and microvascular obstruction, [168] has
also grown greatly. Work has moved on to evaluating
the relation between myocardial damage and aspects
of myocardial function such as dyssynchrony, remodelling,
healing, and determining outcomes, [169] and the indica-
tion for novel treatments [170–172]. Major use of myocar-
dial perfusion imaging by CMR has grown substantially,
[173–175] including assessment of coronary flow reserve,
[176, 177] and technical development [178–181]. The pa-
pers below show how CMR can be used in a number of
ways to characterize acute and chronic coronary disease.
Prediction of long-term segmental and global functional
recovery of hibernating myocardium after revascularisation
based on low dose dobutamine and late gadolinium
enhancement cardiovascular magnetic resonance
This study evaluated the relation between baseline
markers of viability and long-term functional outcome
in 42 patients with ischaemic heart disease after revascu-
larisation [182]. Both the likelihood and time course of
functional improvement were related to LGE transmural-
ity, contractile reserve on low-dose dobutamine (LDD),
and degree of contractile dysfunction at baseline. Pa-
tients with ≥55 % viable segments significantly im-
proved and experienced reverse LV remodelling. A
combination of LDD-CMR and LGE-CMR is a simple
and powerful tool for identifying which patients with im-
paired LV function will benefit from revascularisation.
In vivo contrast free chronic myocardial infarction
characterization using diffusion-weighted cardiovascular
magnetic resonance
A recently developed in vivo diffusion weighted CMR
(dwCMR) technique was compared with LGE in 11 pigs
with chronic MI [183]. Apparent diffusion coefficient
(ADC) maps were derived from three orthogonal diffu-
sion directions and one non-diffusion weighted image.
The study showed that ADC-derived infarct volume and
location had excellent agreement with LGE. In conclu-
sion, dwCMR has the potential to become a contrast-
free alternative to LGE in characterizing chronic MI.
Multiparametric cardiovascular magnetic resonance
surveillance of acute cardiac allograft rejection and
characterisation of transplantation-associated myocardial
injury: a pilot study
This prospective longitudinal study evaluated the per-
formance of multiparametric CMR for detecting acute
cardiac allograft rejection (ACAR) and characterizing
graft recovery following transplantation [184]. Significant
improvements were seen in markers of graft structure
and function (such as LV mass, native T1 and T2,
ECV, circumferential strain, rest and stress myocardial
blood flow) over time. However, none of the CMR
parameters reached statistical significance to detect
ACAR in the 5/22 patients with ACAR on endomyo-
cardial biopsy.
Prevalence and extent of infarct and microvascular
obstruction following different reperfusion therapies in
ST-elevation myocardial infarction
The authors sought to characterise microvascular ob-
struction (MVO) and infarct size (IS) in relation to the
mode and timing of reperfusion in 94 patients with ST-
Elevation Myocardial Infarction (STEMI) [185]. IS was
smaller in the primary PCI and thrombolysis groups
compared to the late PCI and rescue PCI groups. In the
reperfused patient group, time to reperfusion, ischae-
mic area at risk and TIMI grade post-PCI were the
strongest predictors of IS and MVO. MVO was not ex-
clusive of reperfusion therapy and was primarily related
to ischaemic time. These findings have important impli-
cations for clinical trials that use CMR to assess the ef-
ficacy of therapies aimed to reduce reperfusion injury
in STEMI.
Assessment of global myocardial perfusion reserve using
cardiovascular magnetic resonance of coronary sinus flow
at 3 Tesla
Despite increasing clinical use, there is limited data re-
garding regadenoson in stress perfusion CMR. Perfusion
imaging was performed in 117 patients with suspected
myocardial ischaemia and myocardial perfusion reserve
(MPR) was estimated by coronary sinus flow measure-
ments [186]. A subgroup of 41 patients was given ami-
nophylline after the stress images were acquired. MPR
was significantly underestimated 15 min after regadeno-
son injection indicating residual hyperemia, which was
completely reversed after administration of aminophyl-
line. These findings support the routine use of aminoph-
ylline when performing stress CMR with regadenoson.
Comparative cost-effectiveness analyses of cardiovascular
magnetic resonance and coronary angiography combined
with fractional flow reserve for the diagnosis of coronary
artery disease
CMR and fractional flow reserve (FFR) allow for a reli-
able assessment of ischaemia in combination with ana-
tomical information provided by coronary angiography
(CXA). The cost-effectiveness of these two strategies
was compared [187]. CMR + CXA and CXA + FFR were
equally cost-effective at a pretest likelihood of CAD of
62 % in Switzerland, 65 % in Germany, 83 % in the UK,
and 82 % in the US. Below these thresholds, CMR +
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CXA showed lower costs per patient correctly diagnosed
than CXA + FFR. These findings may help to optimize
resource utilization in the diagnosis of CAD.
Voxel-wise quantification of myocardial blood flow with
cardiovascular magnetic resonance: effect of variations
in methodology and validation with positron emission
tomography
This study evaluated the effect of common methodo-
logical differences in CMR voxel-wise measurement of
MBF, using position emission tomography (PET) as
the reference standard [188]. Eighteen subjects (nine
with coronary artery disease and nine healthy volun-
teers) underwent perfusion CMR. MBF was quantified
using 1. Calculated contrast agent concentration curves
(to correct for signal saturation) versus raw signal intensity
curves; 2. Mid-ventricular versus basal-ventricular short-
axis arterial input function (AIF) extraction; 3. Three
different deconvolution approaches; Fermi function
parameterization, truncated singular value decompos-
ition (TSVD) and first-order Tikhonov regularization
with b-splines. MBF was significantly higher when calcu-
lated using signal intensity compared to contrast agent
concentration curves, and when the AIF was extracted
from mid- compared to basal-ventricular images. Agree-
ment between all deconvolution methods was high and
MBF derived using each CMR deconvolution method
showed a significant linear relationship with PET-derived
MBF, however each method underestimated MBF com-
pared to PET (by 0.19 to 0.35 mL/min/g).
Susceptibility-weighted cardiovascular magnetic resonance
in comparison to T2 and T2 star imaging for detection of
intramyocardial hemorrhage following acute myocardial
infarction at 3 Tesla
Detection of intramyocardial haemorrhage (IMH) by
T2-weighted imaging or T2* may be limited by long
breath holds and sensitivity to artefacts, particularly at
3 T. This paper evaluated susceptibility weighted im-
aging (SW MRI) for detection of IMH [189]. Forty-nine
patients post-acute MI patients underwent CMR using
T2-weighted, T2* and SW MRI. SW MRI had shorter
breath hold times than either T2-weighted or T2*, with
comparable diagnostic accuracy and inter-operator reli-
ability to T2-weighted imaging and superior to T2*. SW
MRI therefore provides an accurate and reproducible
method for imaging IMH with considerably shorter
breath hold times to conventional imaging.
Pacemakers
With the approval of some makes of pacemakers and
implantable defibrillators for use in the MR scanner,
there has been considerable interest in reporting their
use and safety, [190, 191] and clinical services are ex-
panded significantly.
Safe performance of magnetic resonance of the heart in
patients with magnetic resonance conditional pacemaker
systems: the safety issue of the ESTIMATE study
The purpose of this study was to analyse safety and po-
tential alterations of electrical lead parameters in 36
patients implanted with the EnRhythm/Advisa MRI
SureScan PM during and after CMR at 1.5 Tesla [192].
No adverse events occurred during CMR or thereafter.
Statistically significant changes were noted on ventricu-
lar sensing, impedance and pacing capture threshold
after the CMR scan albeit clinically irrelevant. Hence
the results suggest CMR to be safe in patients with the
MR conditional EnRhythm/Advisa system.
Immediate and 12 months follow up of function and lead
integrity after cranial MRI in 356 patients with conventional
cardiac pacemakers
This study evaluated the safety of conventional cardiac
pacemakers undergoing cranial MRI at 1.5 Tesla [193].
A total of 356 scans were completed without complica-
tions. No arrhythmias were induced, programmed param-
eters remained unchanged, and no pacemaker dysfunction
was identified. Follow-up examinations performed up to
12 months after the scan did not show any significant
change of pacing capture threshold, sensing threshold or
lead impedance. This supports the evidence that patients
with conventional pacemakers can safely undergo cranial
MRI in a 1.5 T system with suitable preparation, supervi-
sion and precautions.
Varia
There are always papers which do not fall into simple
categories. This section pulls together such varia which
has included interventional CMR techniques, [194–196]
reviews, [197–199] cost-effectiveness, [200] clinical de-
cision making, [201] society reports, [202–204] correc-
tions, [205] registries, [206–208] and novel techniques
[209, 210].
Simplifying cardiovascular magnetic resonance pulse
sequence terminology
The paper presents recommendations for unified terms
to describe CMR pulse sequences based on the purpose
of each sequence rather than the technical approach
[211]. As well as standardizing terminology between
vendors, this may improve written communication be-
tween CMR-requesting clinicians and CMR readers. For
example, T2 weighted sequences would be referred to as
“edema CMR” and T2* as “iron CMR”. For research arti-
cles, use of both simplified and more technical terms
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would allow the methods to be more accessible to non-
expert readers.
Use of oral gadobenate dimeglumine to visualise the
oesophagus during magnetic resonance angiography in
patients with atrial fibrillation prior to catheter ablation
The authors describe a method where an oral gel so-
lution of 0.7 mL gadobenate dimeglumine contrast
was swallowed by patients immediately before a free-
breathing 3D MRA acquisition [212]. The oesophagus
was visualized in 104/105 patients. All patients toler-
ated the study protocol and no complications were
observed. Oesophagus visualization with an oral gadolin-
ium solution is feasible for integration of its anatomy
alongside the left atrium and pulmonary veins into an
electro-anatomical map. The proposed strategy may po-
tentially reduce the risk of atrio-oesophageal fistulae dur-
ing AF radiofrequency ablation.
Vortex flow during early and late left ventricular filling
in normal subjects: quantitative characterization using
retrospectively-gated 4D flow cardiovascular magnetic
resonance and three-dimensional vortex core analysis
Imaging of LV diastolic vortex formation may allow
valuable insights in evaluation of LV function and mea-
sures of LV filling efficiency. 4D Flow CMR was acquired
in healthy volunteers during passive (E) and active (A) dia-
stolic filling using retrospective cardiac gating and 3D vor-
tex analysis [213]. The orientation of the vortex ring core
and ring shape were quantified. The centre of the A-
vortex was significantly closer to the mitral valve annulus
and more elliptical in shape compared to the E-vortex.
There was a strong correlation between the shape of the
vortex and the mitral inflow shape through the annulus
and leaflet tips. Normal values in a cohort of healthy vol-
unteers are reported.
Tracking of stem cells in vivo for cardiovascular
applications
Stem cells for regeneration of the myocardium has re-
ceived much attention over the past 10 years, with con-
flicting trial data regarding efficacy. This review focuses
on the role of CMR in assessment of myocardial regen-
eration and for confirmation of successful cell delivery
and engraftment [214]. Cellular labeling techniques and
their application in CMR and ultrasound are discussed
and trial data to date is reviewed.
Adenosine stress native T1 mapping in severe aortic
stenosis: evidence for a role of the intravascular
compartment on myocardial T1 values
The group assessed the impact of the intravascular com-
partment on native T1 values in a cohort of patients
with severe aortic stenosis studied at rest and adenosine-
induced hyperaemia [215]. As expected, patients had in-
creased myocardial T1 at rest compared to controls,
however, during adenosine stress, T1 values were similar
between AS and controls. Repeat T1 several months
after aortic valve replacement demonstrated a resting
and hyperemic T1 that had recovered towards normal.
Native T1 values are therefore influenced by changes in
the intravascular compartment as well as interstitial and
intracellular fluid changes.
Abbreviations
MA: Mitral annulus; MBF: Myocardial blood flow; MDCTA: Multi-detector
computed tomography angiography; MI: Myocardial infarction; MRA: Magnetic
resonance angiography; MVO: Microvascular obstruction; PCA: Principal
component analysis; PDA: Patent ductus arteriosus; PET: Positron emission
tomography; PH: Pulmonary hypertension; PWV: Pulse wave velocity;
RAD: Renal artery stenosis; RV: Right ventricle; SCD: Sudden cardiac
death; STEMI: ST elevation myocardial infarction; TAVI: Transcatheter
aortic valve implantation; ToF: Tetralogy of Fallot; TSA: Turbo spin echo;
TTE: Transthoracic echocardiography.
Competing interests
All authors declare they have no competing interests.
Authors’ contributions
All authors helped to draft the manuscript. All authors read and approved the
final manuscript.
Received: 6 November 2015 Accepted: 8 November 2015
References
1. Knesewitsch T, Meierhofer C, Rieger H, Rößler J, Frank M, Martinoff S, et al.
Demonstration of value of optimizing ECG triggering for cardiovascular
magnetic resonance in patients with congenital heart disease. J Cardiovasc
Magn Reson. 2013;15:3.
2. Dong SZ, Zhu M, Li F. Preliminary experience with cardiovascular magnetic
resonance in evaluation of fetal cardiovascular anomalies. J Cardiovasc
Magn Reson. 2013;15:40.
3. Seed M, van Amerom JF, Yoo SJ, Al Nafisi B, Grosse-Wortmann L, Jaeggi E,
et al. Feasibility of quantification of the distribution of blood flow in the
normal human fetal circulation using CMR: a cross-sectional study. J Cardiovasc
Magn Reson. 2012;14:79.
4. Kozak MF, Yoo SJ, Mertens L, Ho A, Grosse-Wortmann L. Assessment of
ductal blood flow in newborns with obstructive left heart lesions by
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:45.
5. Hart SA, Devendra GP, Kim YY, Flamm SD, Kalahasti V, Arruda J, et al. PINOT
NOIR: pulmonic insufficiency improvement with nitric oxide inhalational
response. J Cardiovasc Magn Reson. 2013;15:75.
6. Lin YR, Tsai SY, Huang TY, Chung HW, Huang YL, Wu FZ, et al. Inflow-
weighted pulmonary perfusion: comparison between dynamic contrast-
enhanced MRI versus perfusion scintigraphy in complex pulmonary
circulation. J Cardiovasc Magn Reson. 2013;15:21.
7. Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel
ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in
children and adults with congenital heart disease: SCMR expert consensus
group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51.
8. Tobler D, Motwani M, Wald RM, Roche SL, Verocai F, Iwanochko RM, et al.
Evaluation of a comprehensive cardiovascular magnetic resonance protocol
in young adults late after the arterial switch operation for d-transposition of
the great arteries. J Cardiovasc Magn Reson. 2014;16:98.
9. Banka P, Schaetzle B, Komarlu R, Emani S, Geva T, Powell AJ. Cardiovascular
magnetic resonance parameters associated with early transplant-free survival
in children with small left hearts following conversion from a univentricular to
biventricular circulation. J Cardiovasc Magn Reson. 2014;16:73.
10. Broadhouse KM, Finnemore AE, Price AN, Giuliana D, Cox DJ, Anthony E, et
al. Cardiovascular magnetic resonance of cardiac function and myocardial
mass in preterm infants: a preliminary study of the impact of patent ductus
arteriosus. J Cardiovasc Magn Reson. 2014;16:54.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 19 of 25
11. Puranik R, Gray B, Lackey H, Yeates L, Parker G, Duflou J, et al.
Comparison of conventional autopsy and magnetic resonance imaging
in determining the cause of sudden death in the young. J Cardiovasc
Magn Reson. 2014;16:44.
12. Broberg CS, Prasad SK, Carr C, Babu-Narayan SV, Dimopoulos K, Gatzoulis
MA. Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort
study exploring associations of late gadolinium enhancement with clinical
status and survival. J Cardiovasc Magn Reson. 2014;16:32.
13. Ducas RA, Elliott JE, Melnyk SF, Premecz S, da Silva M, Cleverley K, et al.
Cardiovascular magnetic resonance in pregnancy: Insights from the
cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP)
study. J Cardiovasc Magn Reson. 2014;16:1.
14. Ripley DP, Saha A, Teis A, Uddin A, Bijsterveld P, Kidambi A, et al. The
distribution and prognosis of anomalous coronary arteries identified by
cardiovascular magnetic resonance: 15 year experience from two tertiary
centres. J Cardiovasc Magn Reson. 2014;16:34.
15. Latus H, Gummel K, Rupp S, Mueller M, Jux C, Kerst G, et al. Cardiovascular
magnetic resonance assessment of ventricular function and myocardial
scarring before and early after repair of anomalous left coronary artery from
the pulmonary artery. J Cardiovasc Magn Reson. 2014;16:3.
16. Stirrat J, Rajchl M, Bergin L, Patton DJ, Peters T, White JA. High-resolution 3-
dimensional late gadolinium enhancement scar imaging in surgically
corrected Tetralogy of Fallot: clinical feasibility of volumetric quantification
and visualization. J Cardiovasc Magn Reson. 2014;16:76.
17. Rolf A, Rixe J, Kim WK, Börgel J, Möllmann H, Nef HM, et al. Right
ventricular adaptation to pulmonary pressure load in patients with
chronic thromboembolic pulmonary hypertension before and after
successful pulmonary endarterectomy - a cardiovascular magnetic
resonance study. J Cardiovasc Magn Reson. 2014;16:96.
18. Voit D, Zhang S, Unterberg-Buchwald C, Sohns JM, Lotz J, Frahm J. Real-time
cardiovascular magnetic resonance at 1.5 T using balanced SSFP and 40 ms
resolution. J Cardiovasc Magn Reson. 2013;15:79.
19. Krishnamurthy R, Pednekar A, Kouwenhoven M, Cheong B, Muthupillai R.
Evaluation of a subject specific dual-transmit approach for improving B1
field homogeneity in cardiovascular magnetic resonance at 3T. J Cardiovasc
Magn Reson. 2013;15:68.
20. Feng L, Srichai MB, Lim RP, Harrison A, King W, Adluru G, Dibella EV,
Sodickson DK, Otazo R, Kim D. Highly accelerated real-time cardiac cine MRI
using k-t SPARSE-SENSE. Magn Reson Med 2013; 70: 64–74.
21. Busch J, Vannesjo SJ, Barmet C, Pruessmann KP, Kozerke S. Analysis of
temperature dependence of background phase errors in phase-contrast
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:97.
22. Hansen MS, Olivieri LJ, O’Brien K, Cross RR, Inati SJ, Kellman P. Method for
calculating confidence intervals for phase contrast flow measurements.
J Cardiovasc Magn Reson. 2014;16:46.
23. Giese D, Wong J, Greil GF, Buehrer M, Schaeffter T, Kozerke S. Towards
highly accelerated Cartesian time-resolved 3D flow cardiovascular magnetic
resonance in the clinical setting. J Cardiovasc Magn Reson. 2014;16:42.
24. Campbell-Washburn AE, Rogers T, Xue H, Hansen MS, Lederman RJ,
Faranesh AZ. Dual echo positive contrast bSSFP for real-time
visualization of passive devices during magnetic resonance guided
cardiovascular catheterization. J Cardiovasc Magn Reson. 2014;16:88.
25. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision.
J Cardiovasc Magn Reson. 2014;16:2.
26. Kellman P, Xue H, Chow K, Spottiswoode BS, Arai AE, Thompson RB. Optimized
saturation recovery protocols for T1-mapping in the heart: influence of
sampling strategies on precision. J Cardiovasc Magn Reson. 2014;16:55.
27. Kvernby S, Warntjes MJ, Haraldsson H, Carlhäll CJ, Engvall J, Ebbers T.
Simultaneous three-dimensional myocardial T1 and T2 mapping in one
breath hold with 3D-QALAS. J Cardiovasc Magn Reson. 2014;16:102.
28. Wissmann L, Santelli C, Segars WP, Kozerke S. MRXCAT: Realistic numerical
phantoms for cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2014;16:63.
29. Xanthis CG, Venetis IE, Aletras AH. High performance MRI simulations of
motion on multi-GPU systems. J Cardiovasc Magn Reson. 2014;16:48.
30. Motwani M, Kidambi A, Sourbron S, Fairbairn TA, Uddin A, Kozerke S, et al.
Quantitative three-dimensional cardiovascular magnetic resonance
myocardial perfusion imaging in systole and diastole. J Cardiovasc Magn
Reson. 2014;16:19.
31. Jogiya R, Schuster A, Zaman A, Motwani M, Kouwenhoven M, Nagel E, et al.
Three-dimensional balanced steady state free precession myocardial perfusion
cardiovascular magnetic resonance at 3T using dual-source parallel RF
transmission: initial experience. J Cardiovasc Magn Reson. 2014;16:90.
32. Do HP, Jao TR, Nayak KS. Myocardial arterial spin labeling perfusion imaging
with improved sensitivity. J Cardiovasc Magn Reson. 2014;16:15.
33. Liu G, Wright GA. Cardiac gating calibration by the Septal Scout for magnetic
resonance coronary angiography. J Cardiovasc Magn Reson. 2014;16:12.
34. Auger DA, Zhong X, Epstein FH, Meintjes EM, Spottiswoode BS. Semi-
automated left ventricular segmentation based on a guide point model
approach for 3D cine DENSE cardiovascular magnetic resonance.
J Cardiovasc Magn Reson. 2014;16:8.
35. Suever JD, Wehner GJ, Haggerty CM, Jing L, Hamlet SM, Binkley CM, et al.
Simplified post processing of cine DENSE cardiovascular magnetic
resonance for quantification of cardiac mechanics. J Cardiovasc Magn
Reson. 2014;16:94.
36. McGill LA, Ismail TF, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, et al.
Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance
in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012;14:86.
37. McGill LA, Ismail T, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, et
al. Correction: reproducibility of in-vivo diffusion tensor cardiovascular
magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn
Reson. 2013;15:22.
38. Ferreira PF, Kilner PJ, McGill LA, Nielles-Vallespin S, Scott AD, Ho SY, et al. In
vivo cardiovascular magnetic resonance diffusion tensor imaging shows
evidence of abnormal myocardial laminar orientations and mobility in
hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2014;16:87.
39. Axel L, Wedeen VJ, Ennis DB. Probing dynamic myocardial microstructure
with cardiac magnetic resonance diffusion tensor imaging. J Cardiovasc
Magn Reson. 2014;16:89.
40. Tunnicliffe EM, Scott AD, Ferreira P, Ariga R, McGill LA, Nielles-Vallespin S, et al.
Intercentre reproducibility of cardiac apparent diffusion coefficient and fractional
anisotropy in healthy volunteers. J Cardiovasc Magn Reson. 2014;16:31.
41. Matsumoto K, Ehara S, Hasegawa T, Otsuka K, Yamazaki T, Iguchi T, et
al. A case of a lesion containing an intracoronary thrombus detected as
hyperintense plaque on T1-weighted cardiovascular magnetic resonance
in a patient with silent myocardial ischemia. J Cardiovasc Magn Reson.
2013;15:50.
42. Biasiolli L, Lindsay AC, Chai JT, Choudhury RP, Robson MD. In-vivo quantitative
T2 mapping of carotid arteries in atherosclerotic patients: segmentation and
T2 measurement of plaque components. J Cardiovasc Magn Reson. 2013;15:69.
43. Ong MM, Hausotter K, Pilz LR, Schoenberg SO, Michaely HJ. Steady state
vascular imaging with extracellular gadobutrol: evaluation of the additional
diagnostic benefit in patients who have undergone a peripheral magnetic
resonance angiography protocol. J Cardiovasc Magn Reson. 2013;15:97.
44. Calcagno C, Robson PM, Ramachandran S, Mani V, Kotys-Traughber M,
Cham M, et al. SHILO, a novel dual imaging approach for simultaneous
HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular
dynamic contrast enhanced cardiovascular magnetic resonance:
numerical simulations and feasibility in the carotid arteries. J Cardiovasc
Magn Reson. 2013;15:42.
45. Jiji RS, Pollak AW, Epstein FH, Antkowiak PF, Meyer CH, Weltman AL, et al.
Reproducibility of rest and exercise stress contrast-enhanced calf perfusion
magnetic resonance imaging in peripheral arterial disease. J Cardiovasc
Magn Reson. 2013;15:14.
46. Truong U, Fonseca B, Dunning J, Burgett S, Lanning C, Ivy DD, et al. Wall
shear stress measured by phase contrast cardiovascular magnetic resonance
in children and adolescents with pulmonary arterial hypertension. J Cardiovasc
Magn Reson. 2013;15:81.
47. Ebrahimi B, Crane JA, Knudsen BE, Macura SI, Grande JP, Lerman LO. Evolution
of cardiac and renal impairment detected by high-field cardiovascular
magnetic resonance in mice with renal artery stenosis. J Cardiovasc Magn
Reson. 2013;15:98.
48. Dellinger A, Olson J, Link K, Vance S, Sandros MG, Yang J, et al. Functionalization
of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:7.
49. Langham MC, Li C, Englund EK, Chirico EN, Mohler 3rd ER, Floyd TF,
et al. Vessel-wall imaging and quantification of flow-mediated dilation
using water-selective 3D SSFP-echo. J Cardiovasc Magn Reson. 2013;15:100.
50. Grimm JM, Schindler A, Freilinger T, Cyran CC, Bamberg F, Yuan C, et al.
Comparison of symptomatic and asymptomatic atherosclerotic carotid
plaques using parallel imaging and 3 T black-blood in vivo CMR. J
Cardiovasc Magn Reson. 2013;15:44.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 20 of 25
51. Ntsinjana HN, Biglino G, Capelli C, Tann O, Giardini A, Derrick G, et al. Aortic
arch shape is not associated with hypertensive response to exercise in
patients with repaired congenital heart diseases. J Cardiovasc Magn Reson.
2013;15:101.
52. Dormand H, Mohiaddin RH. Cardiovascular magnetic resonance in Marfan
syndrome. J Cardiovasc Magn Reson. 2013;15:33.
53. Mortensen KH, Erlandsen M, Andersen NH, Gravholt CH. Prediction of aortic
dilation in Turner syndrome–the use of serial cardiovascular magnetic
resonance. J Cardiovasc Magn Reson. 2013;15:47.
54. Roberts PA, Cowan BR, Liu Y, Lin AC, Nielsen PM, Taberner AJ, Stewart RA,
Lam HI, Young AA.Real-time aortic pulse wave velocity measurement
during exercise stress testing. J Cardiovasc Magn Reson 2015;17:86.
55. Winter P, Kampf T, Helluy X, Gutjahr FT, Meyer CB, Rommel N, et al. Fast
retrospectively triggered local pulse-wave velocity measurements in mice
with CMR-microscopy using a radial trajectory. J Cardiovasc Magn Reson.
2013;15:88.
56. Langham MC, Englund EK, Mohler 3rd ER, Li C, Rodgers ZB, Floyd TF,
et al. Quantitative CMR markers of impaired vascular reactivity
associated with age and peripheral artery disease. J Cardiovasc Magn
Reson. 2013;15:17.
57. Biglino G, Verschueren P, Zegels R, Taylor AM, Schievano S. Rapid
prototyping compliant arterial phantoms for in-vitro studies and device
testing. J Cardiovasc Magn Reson. 2013;15:2.
58. Uretsky S, Chaudhry FA, Gillam L, Gurram S, Bonda SL, Ponnam H, et al. A
novel technique to quantify the instantaneous mitral regurgitant rate.
J Cardiovasc Magn Reson. 2013;15:74.
59. Garcia J, Capoulade R, Le Ven F, Gaillard E, Kadem L, Pibarot P, et al.
Discrepancies between cardiovascular magnetic resonance and Doppler
echocardiography in the measurement of transvalvular gradient in aortic
stenosis: the effect of flow vorticity. J Cardiovasc Magn Reson. 2013;15:84.
60. Lee SP, Park SJ, Kim YJ, Chang SA, Park EA, Kim HK, et al. Early detection of
subclinical ventricular deterioration in aortic stenosis with cardiovascular
magnetic resonance and echocardiography. J Cardiovasc Magn Reson.
2013;15:72.
61. La Manna A, Sanfilippo A, Capodanno D, Salemi A, Cadoni A, Cascone I, et
al. Left ventricular reverse remodeling after transcatheter aortic valve
implantation: a cardiovascular magnetic resonance study. J Cardiovasc
Magn Reson. 2013;15:39.
62. Groarke JD, Waller AH, Vita TS, Michaud GF, Di Carli MF, Blankstein R, et al.
Feasibility study of electrocardiographic and respiratory gated, gadolinium
enhanced magnetic resonance angiography of pulmonary veins and the
impact of heart rate and rhythm on study quality. J Cardiovasc Magn Reson.
2014;16:43.
63. Roujol S, Foppa M, Basha TA, Akçakaya M, Kissinger KV, Goddu B, et al.
Accelerated free breathing ECG triggered contrast enhanced pulmonary
vein magnetic resonance angiography using compressed sensing. J Cardiovasc
Magn Reson. 2014;16:91.
64. Grimm JM, Schindler A, Schwarz F, Cyran CC, Bayer-Karpinska A, Freilinger T,
et al. Computed tomography angiography vs 3 T black-blood cardiovascular
magnetic resonance for identification of symptomatic carotid plaques.
J Cardiovasc Magn Reson. 2014;16:84.
65. Xie Y, Yu W, Fan Z, Nguyen C, Bi X, An J, et al. High resolution 3D diffusion
cardiovascular magnetic resonance of carotid vessel wall to detect lipid
core without contrast media. J Cardiovasc Magn Reson. 2014;16:67.
66. Rider OJ, Asaad M, Ntusi N, Wainwright E, Clutton G, Hancock G, et al. HIV is an
independent predictor of aortic stiffness. J Cardiovasc Magn Reson. 2014;16:57.
67. Zhu C, Graves MJ, Yuan J, Sadat U, Gillard JH, Patterson AJ. Optimization of
Improved Motion-sensitized Driven-equilibrium (iMSDE) blood suppression
for carotid artery wall imaging. J Cardiovasc Magn Reson. 2014;16:61.
68. Chen H, Sun J, Kerwin WS, Balu N, Neradilek MB, Hippe DS, et al.
Scan-rescan reproducibility of quantitative assessment of inflammatory
carotid atherosclerotic plaque using dynamic contrast-enhanced 3T
CMR in a multi-center study. J Cardiovasc Magn Reson. 2014;16:51.
69. Fan Z, Yu W, Xie Y, Dong L, Yang L, Wang Z, et al. Multi-contrast
atherosclerosis characterization (MATCH) of carotid plaque with a single
5-min scan: technical development and clinical feasibility. J Cardiovasc
Magn Reson. 2014;16:53.
70. Maroules CD, Khera A, Ayers C, Goel A, Peshock RM, Abbara S, et al.
Cardiovascular outcome associations among cardiovascular magnetic
resonance measures of arterial stiffness: the Dallas heart study. J Cardiovasc
Magn Reson. 2014;16:33.
71. Soleimanifard S, Stuber M, Hays AG, Weiss RG, Schär M. Robust volume-
targeted balanced steady-state free-precession coronary magnetic
resonance angiography in a breathhold at 3.0 Tesla: a reproducibility
study. J Cardiovasc Magn Reson. 2014;16:27.
72. Bloch LØ, Hansen AY, Pedersen SF, Honge JL, Kim WY, Hansen ES. Imaging
of carotid artery vessel wall edema using T2-weighted cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2014;16:22.
73. Davis AE, Lewandowski AJ, Holloway CJ, Ntusi NA, Banerjee R, Nethononda
R, et al. Observational study of regional aortic size referenced to body size:
production of a cardiovascular magnetic resonance nomogram. J Cardiovasc
Magn Reson. 2014;16:9.
74. Haraldsson H, Hope M, Acevedo-Bolton G, Tseng E, Zhong X, Epstein FH, et al.
Feasibility of asymmetric stretch assessment in the ascending aortic wall with
DENSE cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:6.
75. Lindsay AC, Biasiolli L, Knight S, Cunnington C, Robson MD, Neubauer S, et
al. Non-invasive imaging of carotid arterial restenosis using 3T
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:5.
76. Hartlage GR, Babaliaros VC, Thourani VH, Hayek S, Chrysohoou C, Ghasemzadeh
N, et al. The role of cardiovascular magnetic resonance in stratifying paravalvular
leak severity after transcatheter aortic valve replacement: an observational
outcome study. J Cardiovasc Magn Reson. 2014;16:93.
77. Donekal S, Ambale-Venkatesh B, Berkowitz S, Wu CO, Choi EY, Fernandes V,
et al. Inter-study reproducibility of cardiovascular magnetic resonance
tagging. J Cardiovasc Magn Reson. 2013;15:37.
78. Heiberg E, Pahlm-Webb U, Agarwal S, Bergvall E, Fransson H, Steding-Ehrenborg
K, et al. Longitudinal strain from velocity encoded cardiovascular magnetic
resonance: a validation study. J Cardiovasc Magn Reson. 2013;15:15.
79. Simpson R, Keegan J, Firmin D. Efficient and reproducible high resolution
spiral myocardial phase velocity mapping of the entire cardiac cycle.
J Cardiovasc Magn Reson. 2013;15:34.
80. Espe EK, Aronsen JM, Skårdal K, Schneider JE, Zhang L, Sjaastad I. Novel
insight into the detailed myocardial motion and deformation of the rodent
heart using high-resolution phase contrast cardiovascular magnetic
resonance. J Cardiovasc Magn Reson. 2013;15:82.
81. Haggerty CM, Kramer SP, Binkley CM, Powell DK, Mattingly AC, Charnigo R,
et al. Reproducibility of cine displacement encoding with stimulated echoes
(DENSE) cardiovascular magnetic resonance for measuring left ventricular
strains, torsion, and synchrony in mice. J Cardiovasc Magn Reson. 2013;15:71.
82. Kramer SP, Powell DK, Haggerty CM, Binkley CM, Mattingly AC, Cassis LA, et
al. Obesity reduces left ventricular strains, torsion, and synchrony in mouse
models: a cine displacement encoding with stimulated echoes (DENSE)
cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2013;
15:109.
83. Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S, et al.
Global and regional left ventricular myocardial deformation measures by
magnetic resonance feature tracking in healthy volunteers: comparison with
tagging and relevance of gender. J Cardiovasc Magn Reson. 2013;15:8.
84. Onishi T, Saha SK, Ludwig DR, Onishi T, Marek JJ, Cavalcante JL, et al.
Feature tracking measurement of dyssynchrony from cardiovascular
magnetic resonance cine acquisitions: comparison with echocardiographic
speckle tracking. J Cardiovasc Magn Reson. 2013;15:95.
85. Wu L, Germans T, Güçlü A, Heymans MW, Allaart CP, van Rossum AC. Feature
tracking compared with tissue tagging measurements of segmental strain by
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:10.
86. Heermann P, Hedderich DM, Paul M, Schülke C, Kroeger JR, Baeßler B, et al.
Biventricular myocardial strain analysis in patients with arrhythmogenic right
ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance
feature tracking. J Cardiovasc Magn Reson. 2014;16:75.
87. Kowallick JT, Kutty S, Edelmann F, Chiribiri A, Villa A, Steinmetz M, et al.
Quantification of left atrial strain and strain rate using Cardiovascular
Magnetic Resonance myocardial feature tracking: a feasibility study.
J Cardiovasc Magn Reson. 2014;16:60.
88. Schneeweis C, Qiu J, Schnackenburg B, Berger A, Kelle S, Fleck E, et al. Value
of additional strain analysis with feature tracking in dobutamine stress
cardiovascular magnetic resonance for detecting coronary artery disease.
J Cardiovasc Magn Reson. 2014;16:72.
89. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et
al. Myocardial T1 mapping and extracellular volume quantification: a Society
for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of
the European Society of Cardiology consensus statement.
J Cardiovasc Magn Reson. 2013;15:92.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 21 of 25
90. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C,
et al. Normal variation of magnetic resonance T1 relaxation times in the human
population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013;15:13.
91. von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, Wassmuth R,
Greiser A, Schwenke C, et al. Myocardial T1 and T2 mapping at 3 T:
reference values, influencing factors and implications. J Cardiovasc Magn
Reson. 2013;15:53.
92. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, et al.
Standardization of T1 measurements with MOLLI in differentiation
between health and disease–the ConSept study. J Cardiovasc Magn
Reson. 2013;15:78.
93. Choi EY, Hwang SH, Yoon YW, Park CH, Paek MY, Greiser A, et al. Correction
with blood T1 is essential when measuring post-contrast myocardial T1
value in patients with acute myocardial infarction. J Cardiovasc Magn
Reson. 2013;15:11.
94. Kellman P, Herzka DA, Arai AE, Hansen MS. Influence of Off-resonance in
myocardial T1-mapping using SSFP based MOLLI method. J Cardiovasc
Magn Reson. 2013;15:63.
95. Raman FS, Kawel-Boehm N, Gai N, Freed M, Han J, Liu CY, et al. Modified
look-locker inversion recovery T1 mapping indices: assessment of accuracy
and reproducibility between magnetic resonance scanners. J Cardiovasc
Magn Reson. 2013;15:64.
96. Kellman P, Arai AE, Xue H. T1 and extracellular volume mapping in the heart:
estimation of error maps and the influence of noise on precision. J Cardiovasc
Magn Reson. 2013;15:56.
97. Tham EB, Haykowsky MJ, Chow K, Spavor M, Kaneko S, Khoo NS, et al.
Diffuse myocardial fibrosis by T1-mapping in children with subclinical
anthracycline cardiotoxicity: relationship to exercise capacity, cumulative
dose and remodeling. J Cardiovasc Magn Reson. 2013;15:48.
98. Statile CJ, Taylor MD, Mazur W, Cripe LH, King E, Pratt J, et al. Left ventricular
noncompaction in Duchenne muscular dystrophy. J Cardiovasc Magn
Reson. 2013;15:67.
99. Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, et al.
Prevalence and distribution of late gadolinium enhancement in a large
population of patients with Duchenne muscular dystrophy: effect of age
and left ventricular systolic function. J Cardiovasc Magn Reson. 2013;15:107.
100. Greally E, Davison BJ, Blain A, Laval S, Blamire A, Straub V, et al.
Heterogeneous abnormalities of in-vivo left ventricular calcium influx and
function in mouse models of muscular dystrophy cardiomyopathy. J Cardiovasc
Magn Reson. 2013;15:4.
101. Quarta G, Husain SI, Flett AS, Sado DM, Chao CY, Tomé Esteban MT, et al.
Arrhythmogenic right ventricular cardiomyopathy mimics: role of
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:16.
102. Kanski M, Arheden H, Wuttge DM, Bozovic G, Hesselstrand R, Ugander M.
Pulmonary blood volume indexed to lung volume is reduced in newly
diagnosed systemic sclerosis compared to normals - a prospective clinical
cardiovascular magnetic resonance study addressing pulmonary vascular
changes. J Cardiovasc Magn Reson. 2013;15:86.
103. Vasu S, Hundley WG. Understanding cardiovascular injury after treatment for
cancer: an overview of current uses and future directions of cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2013;15:66.
104. Wan J, Zhao S, Cheng H, Lu M, Jiang S, Yin G, et al. Varied distributions of late
gadolinium enhancement found among patients meeting cardiovascular
magnetic resonance criteria for isolated left ventricular non-compaction.
J Cardiovasc Magn Reson. 2013;15:20.
105. Captur G, Muthurangu V, Cook C, Flett AS, Wilson R, Barison A, et al.
Quantification of left ventricular trabeculae using fractal analysis.
J Cardiovasc Magn Reson. 2013;15:36.
106. Carpenter JP, Grasso AE, Porter JB, Shah F, Dooley J, Pennell DJ. On myocardial
siderosis and left ventricular dysfunction in hemochromatosis. J Cardiovasc
Magn Reson. 2013;15:24.
107. Pepe A, Meloni A, Rossi G, Cuccia L, D’Ascola GD, Santodirocco M, et al.
Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre
prospective comparison of combined deferiprone and deferoxamine therapy
against deferiprone or deferoxamine monotherapy. J Cardiovasc Magn Reson.
2013;15:1.
108. Junqueira FP, Fernandes JL, Cunha GM, Kubo T TA, Lima C MAO, Lima D BP,
et al. Right and left ventricular function and myocardial scarring in adult
patients with sickle cell disease: a comprehensive magnetic resonance
assessment of hepatic and myocardial iron overload. J Cardiovasc Magn
Reson. 2013;15:83.
109. Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, et al.
Treatment of heart failure in adults with thalassemia major: response in
patients randomised to deferoxamine with or without deferiprone.
J Cardiovasc Magn Reson. 2013;15:38.
110. Child N, Muhr T, Sammut E, Dabir D, Ucar EA, Bueser T, et al. Prevalence of
myocardial crypts in a large retrospective cohort study by cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2014;16:66.
111. de Marvao A, Dawes TJ, Shi W, Minas C, Keenan NG, Diamond T, et al.
Population-based studies of myocardial hypertrophy: high resolution
cardiovascular magnetic resonance atlases improve statistical power.
J Cardiovasc Magn Reson. 2014;16:16.
112. Pica S, Sado DM, Maestrini V, Fontana M, White SK, Treibel T, et al.
Reproducibility of native myocardial T1 mapping in the assessment of
Fabry disease and its role in early detection of cardiac involvement by
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:99.
113. Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, et al. Reference
values for healthy human myocardium using a T1 mapping methodology:
results from the International T1 Multicenter cardiovascular magnetic
resonance study. J Cardiovasc Magn Reson. 2014;16:69.
114. Mikami Y, Kolman L, Joncas SX, Stirrat J, Scholl D, Rajchl M, et al. Accuracy
and reproducibility of semi-automated late gadolinium enhancement
quantification techniques in patients with hypertrophic cardiomyopathy.
J Cardiovasc Magn Reson. 2014;16:85.
115. Ashrith G, Gupta D, Hanmer J, Weiss RM. Cardiovascular magnetic
resonance characterization of left ventricular non-compaction provides
independent prognostic information in patients with incident heart failure
or suspected cardiomyopathy. J Cardiovasc Magn Reson. 2014;16:64.
116. Florian A, Ludwig A, Engelen M, Waltenberger J, Rösch S, Sechtem U,
et al. Left ventricular systolic function and the pattern of late-gadolinium-
enhancement independently and additively predict adverse cardiac events in
muscular dystrophy patients. J Cardiovasc Magn Reson. 2014;16:81.
117. Ismail TF, Hsu LY, Greve AM, Gonçalves C, Jabbour A, Gulati A, et al.
Coronary microvascular ischemia in hypertrophic cardiomyopathy - a
pixel-wise quantitative cardiovascular magnetic resonance perfusion
study. J Cardiovasc Magn Reson. 2014;16:49.
118. Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, et al. Myocardial
fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic
resonance study. J Cardiovasc Magn Reson. 2014;16:59.
119. Giglio V, Puddu PE, Camastra G, Sbarbati S, Della Sala SW, Ferlini A, et al.
Patterns of late gadolinium enhancement in Duchenne muscular dystrophy
carriers. J Cardiovasc Magn Reson. 2014;16:45.
120. Liu T, Pursnani A, Sharma UC, Vorasettakarnkij Y, Verdini D, Deeprasertkul P,
et al. J Cardiovasc Magn Reson. 2014;16:47.
121. te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular
cardiomyopathy (ARVC): cardiovascular magnetic resonance update.
J Cardiovasc Magn Reson. 2014;16:50.
122. Saba SG, Chung S, Bhagavatula S, Donnino R, Srichai MB, Saric M, et al. A
novel and practical cardiovascular magnetic resonance method to quantify
mitral annular excursion and recoil applied to hypertrophic cardiomyopathy.
J Cardiovasc Magn Reson. 2014;16:35.
123. Brouwer WP, Baars EN, Germans T, de Boer K, Beek AM, van der Velden J, et al.
In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial
fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2014;16:28.
124. Masri SC, Misselt AJ, Dudek A, Konety SH. Radiation recall reaction causing
cardiotoxicity. J Cardiovasc Magn Reson. 2014;16:25.
125. Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, et al.
Subclinical myocardial inflammation and diffuse fibrosis are common in
systemic sclerosis – a clinical study using myocardial T1-mapping and
extracellular volume quantification. J Cardiovasc Magn Reson. 2014;16:21.
126. Maceira AM, Ripoll C, Cosin-Sales J, Igual B, Gavilan M, Salazar J, et al. Long
term effects of cocaine on the heart assessed by cardiovascular magnetic
resonance at 3T. J Cardiovasc Magn Reson. 2014;16:26. 23 April 2014.
127. House MJ, Fleming AJ, de Jonge MD, Paterson D, Howard DL, Carpenter JP,
et al. Mapping iron in human heart tissue with synchrotron x-ray
fluorescence microscopy and cardiovascular magnetic resonance.
J Cardiovasc Magn Reson. 2014;16:80.
128. Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, et al.
Calibration of myocardial T2 and T1 against iron concentration. J Cardiovasc
Magn Reson. 2014;16:62.
129. Garbowski MW, Carpenter JP, Smith G, Roughton M, Alam MH, He T, et al.
Biopsy-based calibration of T2* magnetic resonance for estimation of liver
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 22 of 25
iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn
Reson. 2014;16:40.
130. Dodd MS, Ball V, Bray R, Ashrafian H, Watkins H, Clarke K, et al. In vivo
mouse cardiac hyperpolarized magnetic resonance spectroscopy. J Cardiovasc
Magn Reson. 2013;15:19.
131. von Knobelsdorff-Brenkenhoff F, Tkachenko V, Winter L, Rieger J, Thalhammer
C, Hezel F, et al. Assessment of the right ventricle with cardiovascular magnetic
resonance at 7 Tesla. J Cardiovasc Magn Reson. 2013;15:23.
132. Mahajan R, Kuklik P, Grover S, Brooks AG, Wong CX, Sanders P, et al.
Cardiovascular magnetic resonance of total and atrial pericardial adipose
tissue: a validation study and development of a 3 dimensional pericardial
adipose tissue model. J Cardiovasc Magn Reson. 2013;15:73.
133. van Oorschot JW, El Aidi H, Jansen of Lorkeers SJ, Gho JM, Froeling M,
Visser F, et al. Endogenous assessment of chronic myocardial infarction
with T1ρ-mapping in patients. J Cardiovasc Magn Reson. 2014;16:104.
134. Angeli S, Befera N, Peyrat JM, Calabrese E, Johnson GA, Constantinides C. A
high-resolution cardiovascular magnetic resonance diffusion tensor map
from ex-vivo C57BL/6 murine hearts. J Cardiovasc Magn Reson. 2014;16:77.
135. Schuster A, Zarinabad N, Ishida M, Sinclair M, van den Wijngaard JP, Morton
G, et al. Quantitative assessment of magnetic resonance derived myocardial
perfusion measurements using advanced techniques: microsphere validation
in an explanted pig heart system. J Cardiovasc Magn Reson. 2014;16:82.
136. Mahmod M, Francis JM, Pal N, Lewis A, Dass S, De Silva R, et al. Myocardial
perfusion and oxygenation are impaired during stress in severe aortic
stenosis and correlate with impaired energetics and subclinical left
ventricular dysfunction. J Cardiovasc Magn Reson. 2014;16:29.
137. Roldán-Alzate A, Frydrychowicz A, Johnson KM, Kellihan H, Chesler NC,
Wieben O, et al. Non-invasive assessment of cardiac function and pulmonary
vascular resistance in an canine model of acute thromboembolic pulmonary
hypertension using 4D flow cardiovascular magnetic resonance. J Cardiovasc
Magn Reson. 2014;16:23.
138. Troalen T, Capron T, Bernard M, Kober F. In vivo characterization of rodent
cyclic myocardial perfusion variation at rest and during adenosine-induced
stress using cine-ASL cardiovascular magnetic resonance. J Cardiovasc
Magn Reson. 2014;16:18.
139. Radjenovic A, Biglands JD, Larghat A, Ridgway JP, Ball SG, Greenwood JP, et
al. Estimates of systolic and diastolic myocardial blood flow by dynamic
contrast-enhanced MRI. Magn Reson Med. 2010;64:1696–703.
140. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, et al.
Chronic diuretic therapy attenuates renal BOLD magnetic resonance response
to an acute furosemide stimulus. J Cardiovasc Magn Reson. 2014;16:17.
141. Tang YW, Huang TY, Wu WC. Fast and fully automatic calibration of
frequency offset for balanced steady-state free precession cardiovascular
magnetic resonance at 3.0 Tesla. J Cardiovasc Magn Reson. 2013;15:32.
142. Xue H, Kellman P, Larocca G, Arai AE, Hansen MS. High spatial and temporal
resolution retrospective cine cardiovascular magnetic resonance from
shortened free breathing real-time acquisitions. J Cardiovasc Magn Reson.
2013;15:102.
143. Hoerr V, Nagelmann N, Nauerth A, Kuhlmann MT, Stypmann J, Faber C.
Cardiac-respiratory self-gated cine ultra-short echo time (UTE) cardiovascular
magnetic resonance for assessment of functional cardiac parameters at
high magnetic fields. J Cardiovasc Magn Reson. 2013;15:59.
144. Krug JW, Rose G, Clifford GD, Oster J. ECG-based gating in ultra high field
cardiovascular magnetic resonance using an independent component
analysis approach. J Cardiovasc Magn Reson. 2013;15:104.
145. Nyman K, Granér M, Pentikäinen MO, Lundbom J, Hakkarainen A, Sirén R, et
al. Cardiac steatosis and left ventricular function in men with metabolic
syndrome. J Cardiovasc Magn Reson. 2013;15:103.
146. Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ. Reference
right atrial dimensions and volume estimation by steady state free
precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2013;15:29.
147. Medrano-Gracia P, Cowan BR, Bluemke DA, Finn JP, Kadish AH, Lee DC, et
al. Atlas-based analysis of cardiac shape and function: correction of regional
shape bias due to imaging protocol for population studies. J Cardiovasc
Magn Reson. 2013;15:80.
148. Aandal G, Nadig V, Yeh V, Rajiah P, Jenkins T, Sattar A, et al. Evaluation of
left ventricular ejection fraction using through-time radial GRAPPA. J
Cardiovasc Magn Reson. 2014;16:79.
149. Barkauskas KJ, Rajiah P, Ashwath R, Hamilton JI, Chen Y, Ma D, et al.
Quantification of left ventricular functional parameter values using 3D spiral
bSSFP and through-time Non-Cartesian GRAPPA. J Cardiovasc Magn Reson.
2014;16:65.
150. Farber NJ, Reddy ST, Doyle M, Rayarao G, Thompson DV, Olson P, et al. Ex
vivo cardiovascular magnetic resonance measurements of right and left
ventricular mass compared with direct mass measurement in excised hearts
after transplantation: a first human SSFP comparison. J Cardiovasc Magn
Reson. 2014;16:74.
151. Medrano-Gracia P, Cowan BR, Ambale-Venkatesh B, Bluemke DA, Eng J, Finn
JP, et al. Left ventricular shape variation in asymptomatic populations: the
multi-ethnic study of atherosclerosis. J Cardiovasc Magn Reson. 2014;16:56.
152. Hua N, Chen Z, Phinikaridou A, Pham T, Qiao Y, LaValley MP, et al. The
influence of pericardial fat upon left ventricular function in obese females:
evidence of a site-specific effect. J Cardiovasc Magn Reson. 2014;16:37.
153. Posina K, McLaughlin J, Rhee P, Li L, Cheng J, Schapiro W, et al. Relationship
of phasic left atrial volume and emptying function to left ventricular filling
pressure: a cardiovascular magnetic resonance study. J Cardiovasc Magn
Reson. 2013;15:99.
154. Okayama S, Nakano T, Uemura S, Fujimoto S, Somekawa S, Watanabe M, et
al. Evaluation of left ventricular diastolic function by fractional area change
using cine cardiovascular magnetic resonance: a feasibility study.
J Cardiovasc Magn Reson. 2013;15:87.
155. Wu V, Chyou JY, Chung S, Bhagavatula S, Axel L. Evaluation of diastolic
function by three-dimensional volume tracking of the mitral annulus with
cardiovascular magnetic resonance: comparison with tissue Doppler
imaging. J Cardiovasc Magn Reson. 2014;16:71.
156. Schiros CG, Desai RV, Venkatesh BA, Gaddam KK, Agarwal S, Lloyd SG, et al.
Left ventricular torsion shear angle volume analysis in patients with
hypertension: a global approach for LV diastolic function. J Cardiovasc
Magn Reson. 2014;16:70.
157. Schumm J, Greulich S, Wagner A, Grün S, Ong P, Bentz K, et al.
Cardiovascular magnetic resonance risk stratification in patients with
clinically suspected myocarditis. J Cardiovasc Magn Reson. 2014;16:14.
158. Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N,
et al. Native T1-mapping detects the location, extent and patterns of acute
myocarditis without the need for gadolinium contrast agents. J Cardiovasc
Magn Reson. 2014;16:36.
159. Suever JD, Hartlage GR, Magrath III RP, Iravanian S, Lloyd MS, Oshinski JN.
Relationship between mechanical dyssynchrony and intra-operative
electrical delay times in patients undergoing cardiac resynchronization
therapy. J Cardiovasc Magn Reson. 2014;16:4.
160. Sohal M, Duckett SG, Zhuang X, Shi W, Ginks M, Shetty A, et al. A prospective
evaluation of cardiovascular magnetic resonance measures of dyssynchrony in
the prediction of response to cardiac resynchronization therapy. J Cardiovasc
Magn Reson. 2014;16:58.
161. Jaarsma C, Schalla S, Cheriex EC, Smulders MW, van Dongen I, Nelemans PJ,
et al. Incremental value of cardiovascular magnetic resonance over
echocardiography in the detection of acute and chronic myocardial
infarction. J Cardiovasc Magn Reson. 2013;15:5.
162. Jolly US, Soliman A, McKenzie C, Peters T, Stirrat J, Nevis I, et al. Intra-thoracic
fat volume is associated with myocardial infarction in patients with metabolic
syndrome. J Cardiovasc Magn Reson. 2013;15:77.
163. Karim R, Housden RJ, Balasubramaniam M, Chen Z, Perry D, Uddin A, et
al. Evaluation of current algorithms for segmentation of scar tissue from
late gadolinium enhancement cardiovascular magnetic resonance of the
left atrium: an open-access grand challenge. J Cardiovasc Magn Reson.
2013;15:105.
164. Kociemba A, Pyda M, Katulska K, Łanocha M, Siniawski A, Janus M, et al.
Comparison of diffusion-weighted with T2-weighted imaging for detection
of edema in acute myocardial infarction. J Cardiovasc Magn Reson. 2013;15:90.
165. Wassmuth R, Prothmann M, Utz W, Dieringer M, von Knobelsdorff-
Brenkenhoff F, Greiser A, et al. Variability and homogeneity of cardiovascular
magnetic resonance myocardial T2-mapping in volunteers compared to
patients with edema. J Cardiovasc Magn Reson. 2013;15:27.
166. Gao H, Kadir K, Payne AR, Soraghan J, Berry C. Highly automatic
quantification of myocardial oedema in patients with acute myocardial
infarction using bright blood T2-weighted CMR. J Cardiovasc Magn
Reson. 2013;15:28.
167. Chang H, Tran T, Billman GE, Julian MW, Hamlin RL, Simonetti OP, et al.
At-risk but viable myocardium in a large animal model of non ST-segment
elevation acute coronary syndrome: cardiovascular magnetic resonance
with ex vivo validation. J Cardiovasc Magn Reson. 2013;15:94.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 23 of 25
168. Kidambi A, Mather AN, Motwani M, Swoboda P, Uddin A, Greenwood JP, et
al. The effect of microvascular obstruction and intramyocardial hemorrhage on
contractile recovery in reperfused myocardial infarction: insights from
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:58.
169. Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, et al.
Effectiveness of late gadolinium enhancement to improve outcomes
prediction in patients referred for cardiovascular magnetic resonance after
echocardiography. J Cardiovasc Magn Reson. 2013;15:6.
170. Alexandre J, Saloux E, Dugué AE, Lebon A, Lemaitre A, Roule V, et al. Scar
extent evaluated by late gadolinium enhancement CMR: a powerful
predictor of long term appropriate ICD therapy in patients with
coronary artery disease. J Cardiovasc Magn Reson. 2013;15:12.
171. Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, et al. Scar
heterogeneity on cardiovascular magnetic resonance as a predictor of
appropriate implantable cardioverter defibrillator therapy. J Cardiovasc
Magn Reson. 2013;15:31.
172. Yang Y, Connelly KA, Zeidan-Shwiri T, Lu Y, Paul G, Roifman I, et al.
Multi-contrast late enhancement CMR determined gray zone and
papillary muscle involvement predict appropriate ICD therapy in patients with
ischemic heart disease. J Cardiovasc Magn Reson. 2013;15:57.
173. Freed BH, Narang A, Bhave NM, Czobor P, Mor-Avi V, Zaran ER, et al.
Prognostic value of normal regadenoson stress perfusion cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2013;15:108.
174. Vasu S, Bandettini WP, Hsu LY, Kellman P, Leung S, Mancini C, et al.
Regadenoson and adenosine are equivalent vasodilators and are superior
than dipyridamole- a study of first pass quantitative perfusion cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2013;15:85.
175. Boldt J, Leber AW, Bonaventura K, Sohns C, Stula M, Huppertz A, et al.
Cost-effectiveness of cardiovascular magnetic resonance and single-photon
emission computed tomography for diagnosis of coronary artery disease in
Germany. J Cardiovasc Magn Reson. 2013;15:30.
176. Ikuye K, Buckert D, Schaaf L, Walcher T, Rottbauer W, Bernhardt P. Inter-
observer agreement and diagnostic accuracy of myocardial perfusion reserve
quantification by cardiovascular magnetic resonance at 3 Tesla in comparison
to quantitative coronary angiography. J Cardiovasc Magn Reson. 2013;15:25.
177. Kato S, Fukui K, Kawaguchi J, Ishii N, Koga M, Kusakawa Y, et al. Relationship
between coronary flow reserve evaluated by phase-contrast cine cardiovascular
magnetic resonance and serum eicosapentaenoic acid. J Cardiovasc Magn
Reson. 2013;15:106.
178. Harrison A, Adluru G, Damal K, Shaaban AM, Wilson B, Kim D, et al. Rapid
ungated myocardial perfusion cardiovascular magnetic resonance:
preliminary diagnostic accuracy. J Cardiovasc Magn Reson. 2013;15:26.
179. Jogiya R, Makowski M, Phinikaridou A, Patel AS, Jansen C, Zarinabad N, et al.
Hyperemic stress myocardial perfusion cardiovascular magnetic resonance
in mice at 3 Tesla: initial experience and validation against microspheres.
J Cardiovasc Magn Reson. 2013;15:62.
180. Englund EK, Langham MC, Li C, Rodgers ZB, Floyd TF, Mohler ER, et al. Combined
measurement of perfusion, venous oxygen saturation, and skeletal muscle T2*
during reactive hyperemia in the leg. J Cardiovasc Magn Reson. 2013;15:70.
181. Friedrich MG, Karamitsos TD. Oxygenation-sensitive cardiovascular magnetic
resonance. J Cardiovasc Magn Reson. 2013;15:43.
182. Glaveckaite S, Valeviciene N, Palionis D, Puronaite R, Serpytis P, Laucevicius
A. Prediction of long-term segmental and global functional recovery of
hibernating myocardium after revascularisation based on low dose
dobutamine and late gadolinium enhancement cardiovascular magnetic
resonance. J Cardiovasc Magn Reson. 2014;16:83.
183. Nguyen C, Fan Z, Xie Y, Dawkins J, Tseliou E, Bi X, et al. In vivo contrast free
chronic myocardial infarction characterization using diffusion-weighted
cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:68.
184. Miller CA, Naish JH, Shaw SM, Yonan N, Williams SG, Clark D, et al.
Multiparametric cardiovascular magnetic resonance surveillance of acute
cardiac allograft rejection and characterisation of transplantation-associated
myocardial injury: a pilot study. J Cardiovasc Magn Reson. 2014;16:52.
185. Khan JN, Razvi N, Nazir SA, Singh A, Masca NG, Gershlick AH, et al.
Prevalence and extent of infarct and microvascular obstruction following
different reperfusion therapies in ST-elevation myocardial infarction.
J Cardiovasc Magn Reson. 2014;16:38.
186. Dandekar VK, Bauml MA, Ertel AW, Dickens C, Gonzalez RC, Farzaneh-Far A.
Assessment of global myocardial perfusion reserve using cardiovascular
magnetic resonance of coronary sinus flow at 3 Tesla. J Cardiovasc Magn
Reson. 2014;16:24.
187. Moschetti K, Favre D, Pinget C, Pilz G, Petersen SE, Wagner A, et al. Comparative
cost-effectiveness analyses of cardiovascular magnetic resonance and coronary
angiography combined with fractional flow reserve for the diagnosis of
coronary artery disease. J Cardiovasc Magn Reson. 2014;16:13.
188. Miller CA, Naish JH, Ainslie MP, Tonge C, Tout D, Arumugam P, et al.
Voxel-wise quantification of myocardial blood flow with cardiovascular
magnetic resonance: effect of variations in methodology and
validation with positron emission tomography. J Cardiovasc Magn Reson.
2014;16:11.
189. Kidambi A, Biglands JD, Higgins DM, Ripley DP, Zaman A, Broadbent DA, et
al. Susceptibility-weighted cardiovascular magnetic resonance in
comparison to T2 and T2 star imaging for detection of intramyocardial
hemorrhage following acute myocardial infarction at 3 Tesla. J Cardiovasc
Magn Reson. 2014;16:86.
190. Bhandiwad AR, Cummings KW, Crowley M, Woodard PK. Cardiovascular
magnetic resonance with an MR compatible pacemaker. J Cardiovasc Magn
Reson. 2013;15:18.
191. Florian A, Ludwig A, Rösch S, Sechtem U, Yilmaz A. Magnetic resonance of
the heart in a muscular dystrophy patient with an MR conditional ICD:
assessment of safety, diagnostic value and technical limitations. J Cardiovasc
Magn Reson. 2013;15:49.
192. Wollmann CG, Thudt K, Kaiser B, Salomonowitz E, Mayr H, Globits S.
Safe performance of magnetic resonance of the heart in patients with
magnetic resonance conditional pacemaker systems: the safety issue of
the ESTIMATE study. J Cardiovasc Magn Reson. 2014;16:30.
193. Muehling OM, Wakili R, Greif M, von Ziegler F, Morhard D, Brueckmann H, et
al. Immediate and 12 months follow up of function and lead integrity after
cranial MRI in 356 patients with conventional cardiac pacemakers.
J Cardiovasc Magn Reson. 2014;16:39.
194. Halabi M, Faranesh AZ, Schenke WH, Wright VJ, Hansen MS, Saikus CE, et al.
Real-time cardiovascular magnetic resonance subxiphoid pericardial access
and pericardiocentesis using off-the-shelf devices in swine. J Cardiovasc
Magn Reson. 2013;15:61.
195. Halabi M, Ratnayaka K, Faranesh AZ, Hansen MS, Barbash IM, Eckhaus MA, et
al. Transthoracic delivery of large devices into the left ventricle through the
right ventricle and interventricular septum: preclinical feasibility.
J Cardiovasc Magn Reson. 2013;15:10.
196. Khan SN, Rapacchi S, Levi DS, Finn JP. Pediatric cardiovascular interventional
devices: effect on CMR images at 1.5 and 3 Tesla. J Cardiovasc Magn Reson.
2013;15:54.
197. Pennell DJ, Baksi AJ, Kilner PJ, Mohiaddin RH, Prasad SK, Alpendurada F, et
al. Review of J Cardiovasc Magn Reson 2013. J Cardiovasc Magn Reson.
2014;16:100.
198. Ferreira PF, Gatehouse PD, Mohiaddin RH, Firmin DN. Cardiovascular
magnetic resonance artefacts. J Cardiovasc Magn Reson. 2013;15:41.
199. David E, Sosnovik, Ruopeng Wang, Guangping Dai, Timothy G Reese, Van J
Wedeen. Diffusion MR tractography of the heart. J Cardiovasc Magn Reson
2009;11:47.
200. Francis SA, Daly C, Heydari B, Abbasi S, Shah RV, Kwong RY. Cost-effectiveness
analysis for imaging techniques with a focus on cardiovascular magnetic
resonance. J Cardiovasc Magn Reson. 2013;15:52.
201. Abbasi SA, Ertel A, Shah RV, Dandekar V, Chung J, Bhat G, et al. Impact
of cardiovascular magnetic resonance on management and clinical
decision-making in heart failure patients. J Cardiovasc Magn Reson.
2013;15:89.
202. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, Society for
Cardiovascular Magnetic Resonance Board of Trustees Task Force on
Standardized Protocols. Standardized cardiovascular magnetic resonance
(CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91.
203. Carpenter JP, Patel AR, Fernandes JL. Highlights of the 16th annual scientific
sessions of the Society for Cardiovascular Magnetic Resonance. J Cardiovasc
Magn Reson. 2013;15:60.
204. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich
MG, et al. Standardized image interpretation and post processing in
cardiovascular magnetic resonance: Society for Cardiovascular Magnetic
Resonance (SCMR) board of trustees task force on standardized post
processing. J Cardiovasc Magn Reson. 2013;15:35.
205. Abbasi SA, Ertel A, Shah RV, Dandekar V, Chung J, Bhat G, et al.
Correction: Impact of cardiovascular magnetic resonance on
management and clinical decision-making in heart failure patients.
J Cardiovasc Magn Reson. 2014;16:20.
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 24 of 25
206. Petersen SE, Matthews PM, Bamberg F, Bluemke DA, Francis JM, Friedrich
MG, et al. Imaging in population science: cardiovascular magnetic
resonance in 100,000 participants of UK Biobank - rationale, challenges and
approaches. J Cardiovasc Magn Reson. 2013;15:46.
207. Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, et al.
European Cardiovascular Magnetic Resonance (EuroCMR) registry–multi
national results from 57 centers in 15 countries. J Cardiovasc Magn Reson.
2013;15:9.
208. Klinke V, Muzzarelli S, Lauriers N, Locca D, Vincenti G, Monney P, et al.
Quality assessment of cardiovascular magnetic resonance in the setting of
the European CMR registry: description and validation of standardized
criteria. J Cardiovasc Magn Reson. 2013;15:55.
209. Rider OJ, Tyler DJ. Clinical implications of cardiac hyperpolarized magnetic
resonance imaging. J Cardiovasc Magn Reson. 2013;15:93.
210. Steding-Ehrenborg K, Jablonowski R, Arvidsson PM, Carlsson M, Saltin B,
Arheden H. Moderate intensity supine exercise causes decreased cardiac
volumes and increased outer volume variations: a cardiovascular magnetic
resonance study. J Cardiovasc Magn Reson. 2013;15:96.
211. Friedrich MG, Bucciarelli-Ducci C, White JA, Plein S, Moon JC, Almeida AG, et
al. Simplifying cardiovascular magnetic resonance pulse sequence
terminology. J Cardiovasc Magn Reson. 2014;16:3960.
212. Faletti R, Rapellino A, Barisone F, Anselmino M, Ferraris F, Fonio P, et al. Use
of oral gadobenate dimeglumine to visualise the oesophagus during
magnetic resonance angiography in patients with atrial fibrillation prior to
catheter ablation. J Cardiovasc Magn Reson. 2014;16:41.
213. Elbaz MS, Calkoen EE, Westenberg JJ, Lelieveldt BP, Roest AA, van der Geest
RJ. Vortex flow during early and late left ventricular filling in normal
subjects: quantitative characterization using retrospectively-gated 4D flow
cardiovascular magnetic resonance and three-dimensional vortex core
analysis. J Cardiovasc Magn Reson. 2014;16:78.
214. Azene N, Fu Y, Maurer J, Kraitchman DL. Tracking of stem cells in vivo for
cardiovascular applications. J Cardiovasc Magn Reson. 2014;16:7.
215. Mahmod M, Piechnik SK, Levelt E, Ferreira VM, Francis JM, Lewis A, et al.
Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a
role of the intravascular compartment on myocardial T1 values. J Cardiovasc
Magn Reson. 2014;16:92.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pennell et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:99 Page 25 of 25
